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ABSTRACT
Statistical analysis for genomic studies involving measurement error, multiple




Genomic studies involve various types of high-dimensional data. Study designs are
often complex, and data are difficult to collect. For example, the subjects may belong
to distinct populations, the number of subjects is often small, and substantial mea-
surement error is usually present. In this thesis, we consider three important issues
that arise in this research setting. The impact of measurement error on parameter
estimation has been extensively studied, but its effects on predictive performance
have not been. In part 1 of the thesis, we partially characterize the data generating
models that are most adversely impacted by measurement error. These results may
help researchers judge whether improving data collection procedures, or identifying
more informative markers would have a greater impact on predictive performance.
In part 2 of the thesis, we present a new approach for identifying the common and
unique marker/outcome associations that are present in a genomic dataset consisting
of several subpopulations. We show that the natural plug-in style estimates of overlap
are biased, and we demonstrate a copula-based approach to reducing the bias. Part
3 of the thesis considers situations in which power for attributing effects to specific
xiv
markers is low, but meaningful relationships between marker/outcome associations





This thesis considers several challenging issues that arise when analyzing genomic
data. Difficulties that arise in this area commonly result from the effects of covari-
ate measurement error, complicated dependence structure, and data sets with high
dimension and small sample size. In this thesis, we are interested in how covariate
measurement error affects predictive accuracy for outcome prediction under different
data-generating models (chapter 2), the identification of common and unique effects
in multiple subpopulations (chapter 3) and the relationship between effect sizes and
properties of the marginal distributions of the markers (chapter 4).
1.1.1 Impact of covariate measurement error on prediction
Many genomic quantities are not measured with high accuracy. There exist many
sources of measurement errors. In terms of the laboratory measurements, genomic
assays such as microarrays attempt to quantify the abundances of many molecular
types that are present in small amounts in a complex mixture. Such assays are known
to exhibit only partial concordance, even between technical replicates. Moreover, in
research involving human subjects, there may be transient variation within individuals
that is irrelevant for many research goals. Transient qualities of the individuals include
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mood, motivation, degree of alertness, boredom, and fatigue, and situational factors
involving the physical setting such as noise level, lighting and time.
There are many researchers focusing on estimating the reproducibility of microar-
ray data (Larkin et al. (2005), Draghici et al. (2005)) and the signal to noise ratio for
microarray analysis (He and Zhou (2008)). In chapter 2 we use a triplicated expres-
sion array experiment on a panel of 59 cell lines to estimate the signal-to-noise ratio
(SNR) ranges from 3:1 to 8:1. The main statistical focus in this area has been the im-
pact of measurement error on estimation and inference for unknown parameters such
as means and regression coefficients (Fuller (1987), Carroll et al. (2006)). However,
issues resulting from measurement error also arise in predictive analysis. The effect
of measurement error on predictive accuracy has received much less attention.
Chapter 2 considers the effects of covariate measurement error on predictive ac-
curacy. Predictivity declines with increasing measurement error magnitude. But at
a more detailed level, it is unclear whether the absolute or relative amount of decline
in predictivity will differ according to the structure of the outcome generating distri-
bution P (Y |X). Our main focus in this chapter is to consider what attributes of the
distribution P(Y,X) affect the degree to which covariate measurement error adversely
impacts predictive accuracy for binary outcomes.
As an application, we will focus on gene expression used as a quantitative predic-
tor of disease outcomes. Gene expression measurements are made with substantial
measurement error, so it is important to know how this measurement error affects
predictive performance, and whether or not measurement error plays a major role
in limiting prediction accuracy. Doing this would allow researchers to focus on ei-
ther improving measurement technology, or alternatively, on discovering new types
of markers, based on whichever of these two strategies is likely to give the greatest
improvement in predictive performance.
2
1.1.2 Common and unique associations in multiple subpopulations
Graphical displays of effect sizes across many tested variables are often included in
scientific reports, for example, in genetic association studies (Ioannidis et al. (2005),
So and Sham (2010)). But methods for formal analysis of effect size distributions
have only recently been considered. For example, Efron (2007) used the empirical
distribution of effect sizes to calculate false discovery rates. There are many oppor-
tunities to more deeply explore effect sizes in large, complex data sets. For example,
clinical genomic studies often involve populations that can be subdivided into several
distinct subpopulations. Associations between gene expression markers and patient
outcome can be common or unique across such subpopulations.
In chapter 3, we consider the proportion of markers having large marker/outcome
associations in two subpopulations as a measure of the overlap of effect sizes. However,
the simple empirical measure of this overlap can be quite biased. We propose a new
copula-based method to estimate this quantity, and show that it substantially reduces
the bias.
1.1.3 Relationships between marginal properties of variables and their
external correlations
In chapter 4, we consider another aspect of effect size distributions in complex data
sets. Our goal is to consider whether markers that are correlated with an outcome
have different marginal statistical properties than those that are not correlated with
the outcome. We call this a property/marker/outcome association. We present a
method for identifying distributions of genomic markers that are statistically related
to the strengths of the marker/outcome associations.
This leads to a type of integrated correlation measure, for which it is difficult to
assess the statistical properties. Therefore we propose a simulation-based approach to
assess the bias and variability of the estimated property/marker/outcome association.
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Another issue is that there may be not only monotone associations between genomic
markers and the outcome. The non-monotone associations like u-shape association
are not detected by the Pearson correlation coefficient. We develop a way that decom-
poses an association into a monotone component and a symmetric concave/convex
component (plus a residual function) to see which association is dominant.
1.2 The Chronic Kidney Disease dataset
Much of the work described in this thesis was motivated by a genomic dataset
that we call the “Chronic Kidney Disease” (CKD) dataset. Here we give a brief
overview of this dataset. Chronic kidney disease, also known as chronic renal disease,
is a progressive loss of renal function that takes place over a period of months or
years. Chronic kidney disease is identified by a blood test for serum creatinine, with
higher levels of creatinine indicating a falling glomerular filtration rate (GFR) and
as a result a decreased capability of the kidneys to excrete waste products. The
CKD dataset is a collection of clinical and genomic data for subjects with one of
several diseases that give rise to CKD. The diseases in the CKD dataset include
Focal segmental glomerulosclerosis (FSGS), Systemic lupus erythematosus (SLE),
and Minimal Change Disease (MCD).
The genomic data in the CKD dataset consist of microarray measurements of gene
expression on specific cell types obtained from kidney tissue biopsy specimens taken
early in the disease course. The main clinical parameter of interest is the GFR taken at
the biopsy time. GFR is a widely used overall index of kidney function. Specifically,
it estimates how much blood passes through the tiny filters in the kidneys, called
glomeruli, each minute. Normal GFR results range from 90-120 mL/min, GFR below
60 mL/min implies moderate loss of renal function, and GFR below 30 mL/min
is considered to be severe. The dataset includes genomic and clinical data for 195
subjects, and the gene expression data quantify gene expression for 12,023 distinct
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genes or transcripts. While the relatively small number of genes whose function
is specific to the kidneys are of particular interest, CKD is associated with many
physiological processes such as inflammation. Therefore exploratory analyses continue
to play a major role in this area.
A major long-term goal for research in this area is to identify genomic markers
that predict a rapidly declining GFR trend, and to clarify the molecular processes
involved in CKD progression. Much of this work involves correlative analyses in data
sets such as the CKD dataset. The issues discussed in this thesis all address significant
challenges to progress in this field.
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CHAPTER II
Differential effects of covariate measurement error
in outcome prediction
2.1 Introduction
Regression models are often defined in terms of independent variables (covariates)
that are not measured perfectly, or for some reason are not directly observable. In such
situations, error-prone measurements or surrogate covariates, Xobs, are used instead
of the true covariates X. The substitution of Xobs for X usually biases the coefficient
estimates, and much research has been done on methods to correct and adjust for
this bias (Fuller (1987), Carroll et al. (2006)). A related but distinct question is to
consider how prediction methods are impacted by the presence of covariates that are
measured with error. Predictivity must decline with increasing measurement error
magnitude. But at a more detailed level, is the amount of decline strongly dependent
on the structure of the outcome generating distribution P (Y |X)? Our main focus in
this chapter is to consider what attributes of the distribution P(Y,X) might affect the
rate at which covariate measurement error adversely impacts predictive accuracy for
binary outcomes.
As an application, we will focus on gene expression used as a quantitative predic-
tor of disease outcomes. Gene expression measurements are made with substantial
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measurement error, so it is important to know how this measurement error affects
predictive performance, and whether or not measurement error plays a major role
in limiting predictive accuracy. Doing this would allow researchers to focus on ei-
ther improving measurement technology, or alternatively, on discovering new types
of markers, based on whichever of these two strategies is likely to give the greatest
improvement in predictive performance.
We next consider examples of potentially important factors of data generating
models and how they affect the amount of decline in predictive accuracy due to
measurement error. The potential factors are the structure of the covariance matrix
of measurement error Ση, the structure of the covariance matrix of covariates ΣX and
the true regression coefficients β.
First, we generate (X1, X2) ∈ R2 following a centered bivariate normal distribution
with standard deviations 0.5 and correlation r. The binary outcome is generated by
P (Y = 1) = 1/(1+exp (−c(X1 +X2))), where c is a constant which is chosen to make
the Bayes’ rule predictive accuracy with no measurement error equal to 0.9. Then
measurement errors (η1, η2) ∈ R2 which follow independent centered bivariate normal
distribution with standard deviations s are added to the covariates. The Bayes’ rule
predictive accuracy with measurement error magnitude s is calculated and plotted
on figure 2.1 with different values of correlation r (r=0.8, -0.8, and 0). Figure 2.1
focuses on the impact of ΣX on the predictive accuracy while holding other factors
fixed. We see that highly positively correlated covariates exhibit a greater decline of
predictive accuracy than negatively correlated covariates.
Second, we repeat the example above using r = 0 and the binary outcome is
generated by P (Y = 1) = 1/(1 + exp (−c(β1X1 + β2X2))). Define β = (β1, β2).
With the same procedure, the Bayes’ rule predictive accuracy with measurement
error magnitude s is calculated and plotted on figure 2.2 with different structure
of β (β = (1, 1), (1,−1), and (0, 1)). Figure 2.2 focuses on the impact of regression
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coefficients β on the predictive accuracy while holding other factors fixed. We see that
different structure of β will not change the amount of decline of predictive accuracy
very much.
Third, we also repeat the example above using r = 0.8 and the binary outcome
is generated by P (Y = 1) = 1/(1 + exp (−c(X1 +X2))). Here the measurement
errors (η1, η2) are not always independent, they have correlation r̃. With the same
procedure, the Bayes’ rule predictive accuracy with measurement error magnitude s
is calculated and plotted on figure 2.3 with different value of r̃ (r̃ = 0.8,−0.8, and 0).
Figure 2.3 focuses on the impact of Ση on the predictive accuracy while holding other
factors fixed. We see that highly negatively correlated measurement error exhibits
a greater decline of the predictive accuracy than positively correlated measurement
error.
Our overall strategy is to first identify factors that may impact the drop of perfor-
mance in predictive modeling due to measurement error. These factors are identified
from the theoretical derivation of predictive accuracy and from analogies to the linear
case where the issues are much more straightforward. Following our analytic studies,
we then use simulation to assess how the factors we have identified impact the drop
of performance in predictive modeling for binary outcomes, and to assess the rela-
tionships between these factors. Results are given for both linear and binary cases to
see if there is any interpretable difference. To put this to practical use, we will con-
sider how to estimate the key attributes from the data and to estimate the amount of
decline of predictivity in a real data analysis. Another important goal is to estimate
the predictive accuracy that would be obtained if no measurement error were present
from data observed with measurement error.
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Figure 2.1: Example of the impact of the covariance structure of the covariates, Σx
on the decline of predictive accuracy due to measurement error. Upper
Left plot shows the data when the true covariates are highly positively
correlated with r = 0.8; upper right plot shows the data when the true
covariates are highly negatively correlated with r = −0.8; lower left shows
the data when the two true covariates are independent; lower right plot
shows the relationship between Bayes’ rule predictive accuracy ÃUC and
the magnitude of measurement error for three structures of Σx.
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Figure 2.2: Example of the impact of the true regression coefficients β on the decline
of predictive accuracy due to measurement error. Upper Left plot shows
the data when β = c1(1,−1); upper right plot shows the data when
β = c2(1, 1); lower left shows the data when β = c3(0, 1); c1, c2 and
c3 are constants that make the Bayes’ rule predictive accuracy with no
measurement error euqal to 0.9. Lower right plot shows the relationships
between the Bayes’ rule predictive accuracy ÃUC and the magnitude of
measurement error for three structures of β.
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Figure 2.3: Example of the impact of the covariance structure of measurement error,
Ση on the decline of predictive accuracy due to measurement error. Left
plot shows the data without measurement error and right plot shows the
relationships between the Bayes’ rule predictive accuracy ÃUC and the
magnitude of measurement error for three structures of Ση.
2.2 Impact of covariate measurement error on AUC for linear
risk scores
2.2.1 Errors in predictive models
In predictive analysis, the decline of predictive accuracy may be caused by a
misspecified working model, inadequate covariates, sampling error, and/or covariate
measurement error, among other possible factors. Error caused by a misspecified
working model could be reduced by using modern flexible regression and model se-
lection methods. Errors caused by inadequate covariates could be reduced by adding
more covariates. Sampling error could be reduced by increasing the sample size. Our
goal here is to focus on the effects of covariate measurement error. Therefore for com-
parison reasons, we want the other factors remain the same throughout our study.
Thus we use a fixed training set size (p = 10, n = 400) and a fixed outcome-generating
model (e.g. logistic regression). We also hold fixed the Bayes’ rule predictive accuracy
for the model with no measurement error.
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When every configuration has the same Bayes’ rule predictive performance, the
same outcome-generating model and the same regression technique, the decline of
predictive accuracy is solely due to sampling error and measurement error. Then we
can look at the relationship between measurement error and the decline of predictive
accuracy without considering other factors.
2.2.2 Predictive model
We focus on logistic regression model as a predictive model, and we use AUC (area





) = β′X; p = E[Y |X]
where y ∈ {0, 1} is a binary response variable, X is a vector of observed covariates, β
is a vector of regression coefficients. We use β̂′X as a risk score.
2.2.3 Predictive accuracy AUC
When a predictive model for a dichotomous outcomes produces a continuous “risk
score”, a standard procedure for measuring its predictive accuracy is to apply the
model to a test set of subjects whose true responses are known, allowing us to ob-
tain unbiased estimates of sensitivity and specificity for various risk score thresholds.
Sensitivity is defined as the probability that a truly “positive” subject is predicted as
positive, and specificity is the probability that a truly negative subject is predicted as
negative. As the risk score threshold is varied, a non-decreasing relationship between
sensitivity and 1-specificity results. This curve is called the receiver operating char-
acteristic (ROC) curve. The area under ROC curve (AUC) (Dodd and Pepe (2003),
Hanley and McNeil (1982)) is a standard index for diagnostic accuracy, ranging from
0 to 1, with greater values indicating greater accuracy, and AUC = 0.5 indicates
predictive equivalent to random assignment.
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An alternative interpretation of the AUC is that it represents the probability
that a randomly chosen positive example is correctly rated (ranked) with greater
suspicion than a randomly chosen negative example. In logistic regression, we use R1
to represent the risk score for subjects in group Y = 1, and R2 to represent the risk
score for subjects in group Y = 0. Then, we can write
AUC = P (R1 > R2)
Since AUC is an average measure of predictive performance, so is not dependent on
a decision threshold. In addition it is invariant to the marginal class probabilities.
2.2.4 Predictive performance under no measurement error
Define AUC⋆ as the population AUC for a given linear risk score β′X with no
measurement or sampling error. We then define ÃUC as the realized AUC under
measurement error, and when estimating coefficients β from training data as β̂. The
difference between ÃUC and AUC⋆ is the decline of predictive accuracy is our main
interest.
In order to find the the attibutes of the data generating model that have influence
on the decline of predictive accuracy, more insight into AUC is needed.
2.2.5 Analysis of AUC under measurement error
In binary classification, we have two groups of subjects. Suppose in the group
where Y = 1, we have the true covariate X1 and the risk score R1 = β
′X1; in the
group where Y = 0, we have the true covariate X2 and the risk score R2 = β
′X2. The
risk scores are related to a monotone single-index model (Xia (2006)):
P (Y = 1|X) = F (β′X) = p, (2.1)
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where 0 ≤ F (·) ≤ 1, so that 0 ≤ p ≤ 1, and F is a monotone increasing function on
β′X. For example, F (z) = e
z
1+ez
for logit model. The predictive performance for the
limiting risk score β′X under no measurement error is given by
AUC⋆ = P (R1 > R2) = P (β
′X1 > β
′X2).
If X is observed with measurement error η, then in the groups where Y = 1 and
Y = 0, the observed covariate has the form
Xobs1 = X1 + η1, X
obs
2 = X2 + η2, (2.2)
where ηj|Xj are random measurement error with mean 0 and covariance matrix Σηj ,
j = 1, 2. Let β̂ be the estimated regression coefficient of Y on Xobs and β̂ ∼ N(β̃,Σβ̃),
where β̃ is the limiting estimated regression coefficient of Y on Xobs. Our focus in
this chapter is ÃUC with no sampling error or the limiting β̂, β̃. When measurement
error exists, the estimated risk score is defined as
R̃1 = β̃
′Xobs1 = (β̃ − β)′X1 + β̃′η1 +R1,
R̃2 = β̃
′Xobs2 = (β̃ − β)′X2 + β̃′η2 +R2.
The realized predictive performance
ÃUC = P (R̃1 > R̃2)
= P ((β̃ − β)′X1 + β̃′η1 +R1 > (β̃ − β)′X2 + β̃′η2 +R2)
= P (R1 −R2 + (β̃ − β)′(X1 −X2) + β̃′(η1 − η2) > 0)
= P (D + S1 + S2 > 0), (2.3)
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where D = R1 − R2, S1 = (β̃ − β)′(X1 − X2), S2 = β̃′(η1 − η2) are constructed by
random vectors (X1, X2, η1, η2).
To learn how ÃUC is influenced by the factors D, S1 and S2 from the above equa-
tion, the moment structures of D, S1, S2 might be related from our initial intuition
and we could see that the first and second moments of D, S1 and S2 will influence
ÃUC if the following two assumptions hold.
(A1) D + S1 + S2 is from a location scale family that
D + S1 + S2 = σu+ θ,
where σ2 = Var(D+S1+S2), θ = E(D+S1+S2), u is also from location scale
family with mean 0 and variance 1.
(A2) E(R̃1) > E(R̃2) or θ = E(D + S1 + S2) > 0.
From (A1),




where Fu is the cdf of u and a monotone increasing function. Therefore ÃUC will
increase when θ increases. If θ < 0, ÃUC will increase when σ increases; If θ > 0,
ÃUC will increase when σ decreases. From (A2), we know that θ is always greater
than 0, then ÃUC will increase when σ decreases. (A2) is always true since in
our model, P (Y = 1) is a monotone increasing function of the risk score β′X from
equation 2.1, then the group where Y = 1 always has a higher risk score than the
group where Y = 0 on average. AUC > 0.5 is reasonable since the performance of
the classification will always be better than random assignment where AUC = 0.5.
Therefore E(R̃1) > E(R̃2) or θ = E(D+S1+S2) > 0. As a conclusion, we imply ÃUC
will increase when E(D+S1+S2) increases, and will decrease when Var(D+S1+S2)
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increases.
Expand the mean and variance of D+ S1 + S2 to nine terms, which are the mean
of D, S1, S2, the variance of D, S1, S2, and the covariance between D, S1, S2. They
are listed below:
(1) E(D) = E(R1 −R2) = E(β′(X1 −X2)),
(2) E(S1) = E((β̃ − β)′(X1 −X2)),
(3) E(S2) = E(β̃
′(η1 − η2)),
(4) Var(D) = β′ΣX1β + β
′ΣX2β,
(5) Var(S1) = (β̃ − β)′ΣX1(β̃ − β) + (β̃ − β)′ΣX2(β̃ − β),
(6) Var(S2) = β̃
′Ση1 β̃ + β̃
′Ση2 β̃,
(7) Cov(S1, D) = (β̃ − β)′ΣX1β + (β̃ − β)′ΣX2β,
(8) Cov(S2, D) = β̃
′Cov(η1 − η2, X1 −X2)β,
(9) Cov(S1, S2) = (β̃ − β)Cov(η1 − η2, X1 −X2)β̃.
Here we only focus on the effect of measurement error on the decline of ÃUC from
AUC⋆ while holding the model fixed. Then factors (1) and (4) which are not func-
tions of measurement error will not impact the decline of ÃUC from AUC⋆, so will
be removed from the list. While S2 is a direct function of measurement error and S1
is also impacted by measurement error through β̃ which is the estimated regression
coefficient of Y on Xobs with measurement error. With the assumptions from Equa-
tion 2.2, the measurement error η1, η2 have zero means and are independent with our
true covariates X1, X2, then Cov(η1 − η2, X1 −X2) = 0, so S2 is independent with S1
and D. Factors (8) and (9) are approximately zero and will be removed from the list.
Also E(S2) = 0 since the measurement error has zero mean, then factor (3) will be
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removed from the list. At last, there are four factors remaining here that influence
the decline of ÃUC from AUC⋆ due to measurement error, they are
(1) E(S1) = E((β̃ − β)′(X1 −X2)),
(2) Var(S1) = (β̃ − β)′ΣX1(β̃ − β) + (β̃ − β)′ΣX2(β̃ − β),
(3) Var(S2) = β̃
′Ση1 β̃ + β̃
′Ση2 β̃,
(4) Cov(S1, D) = (β̃ − β)′ΣX1β + (β̃ − β)′ΣX2β.
The relationships of these four factors and ÃUC are that ÃUC will increase when
E(S1) increase, ÃUC will increase when Var(S1), Var(S2) and Cov(S1, D) decrease.
Also these relationships could be seen from the lower bound of ÃUC using Chebyshev
inequality and Vysochanskii-Petunin inequality.
Chebyshev inequality: Let M be a random variable with expected value µ and
finite variance σ2. Then for any real number k > 0,












Apply Chebyshev inequality to the equation of ÃUC ( 2.3):
ÃUC = P (R̃1 > R̃2)
= P (R̃1 − R̃2 − E(R̃1 − R̃2) > −E(R̃1 − R̃2))
= 1− P (R̃2 − R̃1 − E(R̃2 − R̃1) > E(R̃1 − R̃2))









M = R̃2 − R̃1 − E(R̃2 − R̃1),




E(R̃1 − R̃2) = E(R1 −R2) + E(S1),
SD(R̃1 − R̃2) =
√
Var(S1) + Var(S2) + Cov(S1, R1 −R2) + Var(R1 −R2).
The lower bound of ÃUC is an increasing function of K, and then is an increasing
function of E(S1) and a decreasing function of Var(S2), Var(S1), Cov(S1, R1 − R2).
Since the lower bound of ÃUC using chebyshev’s inequality is not tight enough,
we could use Vysochanskii-Petunin inequality which assume unimodality of random
variable X instead. But the relationships of our four properties and ÃUC do not
change.
Vysochanskii-Petunin inequality: Let M be a random variable with expected value
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µ and finite variance σ2. Then for any real number k > 0,
P (|M − µ| ≥ Kσ) ≤ 4
9K2
.
From the theoretical derivation of AUC, we know that there are four properties
of the data generating model influence the decline of AUC caused by measurement
error. We imply the relationship of these four properties and ÃUC under the assump-
tion of the location-scale family and from the lower bound of ÃUC. Next, we will
confirm these relationships by simulation studies and explore more about the rela-
tionships between these four properties themselves, then decide the miminum number
of properties which influence the amount of decline of ÃUC.
2.3 Simulation approach
2.3.1 Gene expression data
Since we want the data generating model in our simulation study to be close
enough to the real data, many parameters or attributes in my simulation study is
chosen by calibrating them from the real data.
We use the data set for Microarray Innovations in Leukemia (MILE) study pro-
gram with n=2096 sample sizes devided into 18 classes and over thousands of genes.
We focus on the two classes “CLL” and “AML with normal karyotype + other ab-
normalities” which have the largest sample sizes which are 448 and 351. We split
the data evenly into two subgroups, one for identifying the significant genes used as
covariates from some criterions, (e.g. who have their gene expression values most
different comparing these two classes using t statistics), the other subgroup is used
to estimate the distribution of β̂ which is the estimated coefficient of the logistic
regression of the observed two classes on the gene covariates we just selected.
Here we use three methods to select the genes to be used in our simulation study.
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One is choose 10 genes having the highest t values comparing the two classes, and
we could also choose the next 10 genes having the highest t values except the first
10 genes and so on. The limitation of this method is the genes we choose are highly
positive or negative correlated with each other (e.g. ρ̄ = 0.75 which is the average
pairwise correlation of the first 10 genes having the highest t values in MILE data),
the high multicollinearty will lead to opposite sign of estimated coefficients β̂ and
larger covariance matrix of β̂, which will lead to more unstable result.
The second method is that we choose 10 genes whose pairwise correlation less than
some fixed value (e.g. ρ < 0.7) and have higher t values also. In more details, we
order our genes with their t values from high to low and we could choose the first gene
having the highest t value. Then search the genes by the order until its correlation
with the first gene is less than 0.7. Then search the third gene until its correlation
with the first and the second are both less than 0.7 and go on. This method controls
the multicollearity of the genes and the 10th gene still has t value greater than 2 in
MILE data.
The third method is that we choose 10 genes randomly from all the genes and
they are expected to be independent with each other. From these three methods,
we could generate three structures of ΣX in which the distribution of the pairwise
correlations between covariates are approximately normal with mean µ and standard
deviation σ. In MILE data, µ = 0.7, σ = 0.1 for the first method; µ = 0.5, σ = 0.1
for the second method; µ = 0.2, σ = 0.1 for the third method.
2.3.2 Simulation steps
1. We construct the true covariates X without measurement error, having covari-
ance matrix Σx. Figure 2.4 are the examples of pattern of elements in co-
variance matrix of X using gene expression data from MILE study by three
different methods illustrated above. From these examples, we could see that
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Figure 2.4: Left plot is the histogram of the correlations of pairs of genes selected from
method 1; middle plot is the histogram of the correlations of pairs of genes
selected from method 2; third plot is the histogram of the correlations of
pairs of genes selected from method 3.
the elements in covariance matrix of predictors are approximately normally dis-
tributed with different mean and standard deviation. We need the elements in
Σx in my simulation study has the same distribution with that in MILE study.
Let Σx = I + FF
′, where F = (f1, · · · , fp)T . The elements of corresponding





, i ̸= j. We used a numerical optimization scheme
to optimize the fit of elements in Σx = I + FF
′ to a normal distribution over
F. The Kolmogorov-Smirnov distance was used to assess the fit. The normal
distribution of the elements in ΣX has three different sets of mean and standard
deviation: (µ = 0.7, σ = 0.1); (µ = 0.5, σ = 0.1); (µ = 0.2, σ = 0.1).
2. Generate true coefficients β with known structure.
We have two ways to generate β:
(1) Use βj = ±c × 2(1−j)d, j = 0, 1, · · · to define a family of true coefficient
vectors with different patterns. Figure 2.5 is an example of this kind of β.
(2) Generate a set of population β vectors by sampling from the distribution
N(β0,Σ0), where β0 is the estimated logistic regression coefficient for the
observed two classes and selected gene expression data set in MILE study.
3. Control AUC⋆ = 0.9 and set balance of outcome to be 0.6 with known struc-
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Figure 2.5: left plot is examples of different structure of true coefficient β has struc-
ture βj = ±c × 2(1−j)d, j = 0, 1, · · · with c = 1 and different value of
parameter d; Right plot is examples of scaling constant c with different
AUC⋆ and β.
ture of X and β by setting the scaling constant c of β using bisection numerical
method. AUC⋆ is the predictive performance with no measurement and sam-
pling error. Since we are only interested in the effect of measurement error on
predictive performance, for comparison reason, we need every data generating
model in my simulation study have the same AUC⋆. From figure 2.5, we know
the scaling constant c increases with the increase of AUC⋆. Different pattern
of β has different scaling constant c.
4. Calibrating the magnitude of measurement error.
In measurement error analysis, it is almost always necessary to have an internal
or external measure of the level of measurement error. For gene expression
analysis, internal replication is uncommon. Therefore, to estimate the level
of measurement error among gene expression predictors, we use a triplicated
expression array experiment on a panel of 59 cell lines. Specifically, given three




i=1(xi − x̄)2 unbiasedly estimates the measurement
error for a particular gene in a particular cell line. We then average over the
cell lines and consider the relationship between measurement error standard
deviation and overall standard deviation in Figure 2.6. Focusing on the trend
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Figure 2.6: Plot of measurement error standard deviation and overall standard devi-
ation in a triplicated expression array data.
line in the left panel, we see that measurement error standard deviation increases
linearly at first, then becomes independent of the overall standard deviation.
This suggests a fixed additive variance due to measurement error, except for
the genes that are nearly constant. Many of these nearly constant genes are
non-responsive probes, where measurement error would not be expected to be
detectable. Taking the middle of the range as a nominal value, we arrive at
signal-to-noise ratio (SNR) estimates from 3:1 to 8:1.
5. Simulate binary response Y with linear predictor β′X by




then add independent measurement error with different magnitude probably
between 0 to 1 to standardized X to create Xobs, then calculate ÃUC by using
estimated risk score β̂′X, where β̂ is the estimated coefficient of logistic regres-
sion of Y on Xobs. Repeat step 5 100 times to estimate β̃ by averaging the values
of β̂ in each repetition and then since the covariance matrix of measurement
error Ση, covariance matrix of the true covariates ΣX , true coefficient β are all
known, we could estimate the value of these four factors of the data generating
model
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(1) E(S1) = E((β̃ − β)′(X1 −X2)),
(2) Var(S1) = (β̃ − β)′ΣX1(β̃ − β) + (β̃ − β)′ΣX2(β̃ − β),
(3) Var(S2) = β̃
′Ση1 β̃ + β̃
′Ση2 β̃,
(4) Cov(S1, D) = (β̃ − β)′ΣX1β + (β̃ − β)′ΣX2β.
and make graphs of each of the four factors and ÃUC.
In simulation step 5, we add independent measurement errors to the true covariate
X. But in real data, the measurement errors could be dependent with each other and
the covariance matrix of measurement error does not equal to identity matrix, Ση ̸= I.
But we could guarantee that with some matrix transformations, we could assume that





) = β′X; p = E[Y |X],
with true regression coefficient β, true covariate X, and the measurement error added
to the covariate η, with E(η|X) = 0, and covariance matrix Ση. Then the risk score
with measurement error is β′(X + η). By Cholesky decomposition, Ση = RR
′, where
R is a lower triangular matrix. Let
η̃ = R′−1η, X̃ = R′−1X, β̃ = Rβ,
Then the risk score with measurement error is β̃′(X̃ + η̃) = β′(X + η) will not change
with Ση̃ = I.
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Figure 2.7: Plot of ÃUC and measurement error SD magnitude with different level
of AUC⋆.
2.4 Simulation results for logistic regression
2.4.1 Question 1: Will the effect of covariate measurement error on pre-
dictive performance be different with different level of AUC⋆?
Since we only interest in the decline of predictive accuracy, AUC⋆ − ÃUC due to
measurement error, whether or not to fix AUC⋆ is a question. With different level of
AUC⋆, if AUC⋆ − ÃUC is not effected by AUC⋆, then we do not need to fix AUC⋆.
From intuition, 0 ≤ ÃUC ≤ AUC⋆ due to measurement error. If AUC⋆ ≈ 0.5,
then ÃUC also ≈ 0.5. We expect AUC⋆− ÃUC to be greater when AUC⋆ is greater.
We could also use simple simulation to check this.
Choose Σx with µ = 0.2, σ = 0.1, β = (1,−1, · · · , 1,−1), Ση = s2I with s ranging
from 0.0 to 0.7. Vary AUC⋆ from 0.5 to 0.9, from figure 2.7, we could see that the
decline of predictive accuracy is different with different level of AUC⋆ due to the
same amount of measurement error. In our following simulation study, we always use
AUC⋆ = 0.9.
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Figure 2.8: Left Plot is the plot of ÃUC and measurement error SD magnitude with
different β when Σx = Ση = I; right Plot is the plot of ÃUC and mea-
surement error SD magnitude with different β when the elements in Σx
has normal distribution with µ = 0.2, σ = 0.1 and Ση = I.
2.4.2 Question 2: For fixed AUC⋆, does the relationship between ÃUC
and measurement error variance depend on β,Σx,Ση?
From the example we show at the beginning of this paper, we know that some
attributes of data generating model, like β,Σx,Ση will influence the decline of pre-
dictive accuracy due to measurement error and in some situations, the influence is
small, in other situations, the influence is dramatic.
From figure 2.8, when Σx = Ση = I, no matter how we choose β, the decline of
ÃUC is same. But when Σx ̸= Ση, different structure of β has different ÃUC with
the same amount of measurement error.
From the simulation study we know that some attributes of data generating model,
like β,Σx,Ση will influence the decline of predictive accuracy due to measurement er-
ror in most case, but we do not know exactly how these attributes influence predictive
accuracy while question 3 does.
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2.4.3 Question 3: What is the relationship of the four factors we find
through theoretical derivation of AUC and how them effect the
decline of ÃUC ?
From the theoretical derivation of AUC, we know there are four factors that will
influence the decline of ÃUC when fixing AUC⋆. They are
(1) E(S1) = E((β̃ − β)′(X1 −X2)),
(2) Var(S1) = (β̃ − β)′ΣX1(β̃ − β) + (β̃ − β)′ΣX2(β̃ − β),
(3) Var(S2) = β̃
′Ση1 β̃ + β̃
′Ση2 β̃,
(4) Cov(S1, D) = (β̃ − β)′ΣX1β + (β̃ − β)′ΣX2β.
We also imply how they effect the decline of ÃUC that greater E(S1) lead to
higher ÃUC, greater Var(S2), Var(S1), Cov(S1, R1−R2) will lead to lower ÃUC from
the theoretical derivation of the definition of AUC. Then we will check if we have the
similar relationships in our simulation study.
In our simulation study, we generate covariate X with covariance matrix Σx, whose
off-diagonal element has approximately normal distribution with three sets of mean
and standard deviation, (1) µ = 0.7, σ = 0.1; (2) µ = 0.5, σ = 0.1; (3) µ = 0.2,
σ = 0.1. True coefficient β is generate with distribution N(β0,Σ0), where β0 is the
estimated logistic regression coefficient for the observed two classes and selected gene
expression data set in MILE study from three different methods. Control AUC⋆ = 0.9
by multiplying a constant c to β and then the true binary outcome Y is generated
with the linear predictor cβ′X. Add independent measurement error with magnitude
from 0 to 1 to the covariates X, then the estimated predictive accuracy ÃUC and the
estimates of the four factors are calculated.
Figure 2.9 is the plots of the relationships between ÃUC and the magnitude
of measurement error with the three sets of mean and standard deviation of the
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distribution of the elements in Σx. The plot shows that overall ÃUC decline with the
increasing magnitude of measurement error and the variation of ÃUC due to different
structure of true coefficient β increase with increasing magnitude of measurement
error. When the distribution of the elements in Σx has lower mean, the decline of
ÃUC due to measurement error is smaller.
Figure 2.10 shows the relationship between ÃUC and the four factors of the data
generating model with the three sets of mean and standard deviation of the distri-
bution of the elements in Σx. We could see that E(S1) has a positive relationship
with ÃUC, while Var(S2), Var(S1), Cov(S1, X1−X2) have negative relationships with
ÃUC.
Figure 2.11 shows the relationships of these four factors themselves and we could
see that E(S1), Var(S1) and Cov(S1, X1 −X2) are highly dependent with each other,
while Var(S2) is independent of them. We choose Var(S1) and Var(S2) as the main
factors that influence the decline of ÃUC.
As a conclusion, in binary outcome predictive, predictive performance is negatively
affected by the increase of magnitude of measurement error. Moreover, the effect
is influenced by other attributes of data generating model. From the theoretical
derivation of predictive accuracy AUC, we find that there are four factors might
influence the decline of predictive accuracy ÃUC when controlling AUC⋆ and find
similar results in the simulation study that E(S1) has a negative relationship with the
decline of ÃUC, while Var(S2), Var(S1), Cov(S1, X1−X2) have positive relationships
with the decline of ÃUC. From these four factors, we find two independent factors
Var(S2) = β̃
′Ση1 β̃ + β̃
′Ση2 β̃,
Var(S1) = (β̃ − β)′ΣX1(β̃ − β) + (β̃ − β)′ΣX2(β̃ − β),
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Figure 2.9: Plots of ÃUC and measurement error SD magnitude with different β
generated from N(β0,Σ0) with three situations of mean and standard de-
viation of the distribution of the elements in Σx. Left plot is the situation
when µ = 0.2, σ = 0.1; middle plot is the situation when µ = 0.5, σ = 0.1;
right plot is the situation when µ = 0.7, σ = 0.1.
could be representative of these four factors and both of them have linearly positive
relationships with the decline of AUC. But there is not enough theoretical proof for
these relationships since there is no close form of the estimated regression coefficient
β̂, then we could not get a close form of the predictive accuracy AUC. However,
this could be done in linear regression. We are interested in whether we could find
similar properties and relationships between these properties and predictive accuracy
in linear case?
2.5 Similar finding in linear case
2.5.1 linear model and predictive accuracy
Linear Model:
Y = β′X + ϵ
E(ϵ|X) = 0,Var(ϵ|X) = σ2ϵ
Define β̃ as the estimated linear regression coefficient when regressing continuous
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Figure 2.10: Plots of ÃUC and four factors of the data generating model with differ-
ent β and measurement error in three situations of mean and standard
deviation of the distribution of the elements in Σx. Left plot is the situ-
ation when µ = 0.2, σ = 0.1; middle plot is the situation when µ = 0.5,
σ = 0.1; right plot is the situation when µ = 0.7, σ = 0.1. First row
is for factor Var(S2), second row is for factor Var(S1), third row is for
factor E(S1), fourth row is for factor Cov(S1, D).
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Figure 2.11: Scatterplots of these four factors in the simulation study when µ = 0.5,
σ = 0.1.
outcome Y on covariates X, and the sample size goes to infinity, then
β̃ = E(β̂) = (ΣX + Ση)
−1ΣXβ,
where β̂ is the estimated linear regression coefficient when regressing Y on X and
β̃ = β when no measurement error exists. Predictive accuracy in linear model without
sampling error:
R2 = 1− ∥Ŷ − Y ||
2
||Y − Ȳ ∥
= 1− ∥β̃
′Xobs − β′X − ϵ∥2
β′ΣXβ + σ2ϵ
Predictive accuracy without sampling and measurement error:
R2ideal = 1−










Predictive accuracy with measurement error:
R̃2 = 1− ∥(β̃ − β)
′X + β̃′η − ϵ∥2
β′ΣXβ + σ2ϵ
Since ϵ, η, X are independent with each other, then (β̃−β)′X, β̃′η, ϵ are independent.
Therefore,
R̃2 = 1− (β̃ − β)




S1 = (β̃ − β)′X, S2 = β̃′η,




To make each outcome-generating model has the same best predictive performance,
we need to fix R2ideal, and σ
2
ϵ is known, then β
′ΣXβ is fixed. R̃2 is affected by only
two properties:
(1) Var(S2) = β̃
′Σηβ̃,
(2) Var(S1) = (β̃ − β)′ΣX(β̃ − β).
These two factors have negative relationships with R̃2. Then we use the simulation
study to show that we could find similar relationships between R̃2 and the two factors
Var(S1), Var(S2) of the linear model. The simulation steps are quite similar with those
for binary case. We first generate covariate X with covariance matrix Σx, whose off-
diagonal element has approximately normal distribution with three sets of mean and
standard deviation, (1) µ = 0.7, σ = 0.1; (2) µ = 0.5, σ = 0.1; (3) µ = 0.2,
σ = 0.1. True coefficient β is generate with distribution N(β0,Σ0), where β0 is the
estimated logistic regression coefficient for the observed two classes and selected gene
expression data set in MILE study from three different methods. Control R2ideal = 0.9
by multiplying a constant c to β, and then the true continuous outcome Y is generated
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with the linear predictor cβ′X by
Y = cβ′X + ϵ,
where E(ϵ|X) = 0,Var(ϵ|X) = 1. Then add independent measurement error with
magnitude from 0 to 1 to the covariates X, then the estimated predictive accuracy R̃2
and the estimate of the two factors are calculated. The relationship between each of
the two factors and R̃2 and the relationship between the two factors themselves are
shown in figure 2.12. It indicates that larger amount of the values of the two factors
will lead to larger amount of the decline of the predictive accuracy R2ideal − R̃2 and
this finding is consistent with the finding in binary case.
2.6 Estimation of these attributes from real data
To put our finding to practical use, we need to estimate these two factors Var(S2) =
β̃′Σηβ̃ and Var(S1) = (β̃ − β)′ΣX(β̃ − β) correctly from real data. In real data,
we observe outcome Y and covariates Xobs with measurement error and covariance
matrix of measurement error Ση, then we could estimate the true covariance matrix
of X using the equation Σ̂X = ΣXobs − Ση and calculate β̂ which is the mle of β. In
linear regression, we have
β̃ = E(β̂) = (ΣX + Ση)
−1ΣXβ,
then
β = (ΣX + Ση)Σ
−1
X β̃.
Thus the two key factors can be wrote as:
(1) Var(S2) = β̃
′Σηβ̃,
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Figure 2.12: First row is the plots of R̃2 and measurement error SD magnitude with
different β; second row is the plots of R̃2 and factor Var(S2); third row is
the plots of Plots of R̃2 and factor Var(S1); fourth row is the scatterplots
of Var(S2) and Var(S1). There are three situations of mean and standard
deviation of the distribution of the elements in Σx. Left plot is the
situation when µ = 0.2, σ = 0.1; middle plot is the situation when
µ = 0.5, σ = 0.1; right plot is the situation when µ = 0.7, σ = 0.1.
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(2) Var(S1) = β̃
′Mβ̃,
M = (I − (ΣX + Ση)Σ−1X )′ΣX(I − (ΣX + Ση)Σ
−1
X ).
By using the equation,
β̂′Σηβ̂ = tr(ΣηE(β̂β̂
′))






the first factor Var(S2) could be estimated by
Var(S2) = β̂
′Σηβ̂ − σ̂2tr(Ση(X ′obsXobs)−1),
where σ̂2 = ∥Y−Ŷ ∥
2
n−p−1 . With the same procedure, Var(S1) could be estimated by
Var(S1) = β̂
′Mβ̂ − σ̂2tr(M(X ′obsXobs)−1).
In binary case, the estimation for property Var(S2) = β̃
′Σηβ̃ is the same as in
linear case. But since there is no exact equation of β̃ and β, so we could not transform
Var(S1) to the format β̃
′Mβ̃. Alternatively, we use a simex procedure to estimate
β̃−β. We calculate β̂1 by regressing Y onX+η, and β̂2 by regressing Y onX+2η, then
β̃−β ≈ β̂2− β̂1. Though we could calculate Σx by using equation Σ̂x = Σxobs −Ση, we
are not able to calculate ΣX1 or ΣX2 in binary case, since the distribution of covariates
in each group is unknown. Then in binary case, we use Var(S1) = (β̂2−β̂1)′Σ̂x(β̂2−β̂1)
instead.
Figure 2.13 is the plot of estimated and true factors in simulation study and it
shows that the estimation is very precise in linear case, but the estimation of Var(S1)
by simex procedure is not very precise in binary case. The simulation steps are the
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Figure 2.13: First two Plots are the scatterplots of True and estimated properties in
linear case; last two Plots are the scatterplots of True and estimated
properties in binary case when µ = 0.5, σ = 0.1.
same with the simulation we used to get the relationships between ÃUC and the four
factors in section 2.3.2.
In linear case, since we could estimate Var(S1), Var(S2), β
′ΣXβ, σ
2 from ob-
served data, we could calculate R2ideal and R̃
2 and the decline of predictive accuracy
R2ideal − R̃2. We could use a ratio of predictive accuracy due to measurement error
and overall decline of predictive accuracy from 1,
R2ideal−R̃2
1−R̃2
to see how much decline
of predictive accuracy is due to measurement error. If the ratio is large, which means
the effect of measurement error is dominate, we should pay more attention on im-
proving measurement technique. If the ratio is small, then we could focus on use
more advanced regression techniques or find more variables or collect more samples
to reduce other errors causing the decline of predictive accuracy.
2.7 conclusion and future direction
This chapter focuses on the statistical assessment of predictive performance due
to covariate measurement error. Overall, the predictive performance is negatively af-
fected by the increase of magnitude of measurement error. The effect is also influenced
by other attributes of data generating model related to the true regression coefficient
β, the covariance matrix of true covariates X, Σx, and the covariance matrix of the
measurement error, Ση. From the theoretical derivation of predictive accuracy AUC,
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we find that there are four factors might influence the decline of predictive accuracy
ÃUC when controlling AUC⋆ and similar findings is shown for the linear case. Then
in the simulation study, we find that E(S1) has a negative relationship with the de-
cline of ÃUC, while Var(S2), Var(S1), Cov(S1, X1 − X2) have positive relationships
with the decline of ÃUC. From these four factors, we find two independent factors,
Var(S2), Var(S1) could be representative of these four factors and both of them have
linearly positive relationship with the decline of AUC.
To apply this to practical use, we propose a SIMEX procedure to estimate these
two factors from real data, though the estimate is not very accurate. Then we define
a ratio of the decline of predictive accuracy due to measurement error compare to the
overall decline of predictive accuracy. If the ratio is large, the effect of measurement
error dominate the decline of predictive accuracy, otherwise, we do not need to worry
much about the measurement error. This could help researchers to decide whether to
improve technologies to measure the data more accurately or to use more advanced
regression techniques, find more relevant covariates or collect more samples to reduce
other errors causing the decline of predictive accuracy.
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CHAPTER III
Common and unique associations in screening
analyses with multiple subpopulations
3.1 Introduction
Many genomic studies involve the analysis of large numbers of association pa-
rameters. One such example would be a biomarker screening study in which a large
number of candidate markers are assessed for potential use as predictors of an outcome
of interest. The association parameter may be calculated between a single outcome
and each of thousands of potential molecular markers. Such studies often involve
populations that can be subdivided into several distinct subpopulations. Then it is
of interest to ask whether the marker/outcome associations are similar or different
among the subpopulations and to estimate the proportion of markers having large
effect in both subpopulations.
To set notations, let Xij, where i = 1, · · · ,m denote a set of markers, and let
j = 1, · · · , n denote independent research subjects. The Xij may represent gene
expression, genotype, DNA copy number, protein expression, DNA methylation, or
any of a number of other molecular assays. The molecular marker data are typically
then compared to a phenotype or outcome Yj (j = 1, · · · , n) to identify markers
that may be used to predict the outcome, or that may mechanistically influence
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the outcome. For univariate analysis, common association statistics are the Pearson
correlation coefficient ρ̂i calculated between the i
th marker and the outcomes, or the
standardized two-group difference of mean marker levels (if the Yj indicate group
membership). To be concrete, we will use correlation coefficients in our presentation
here, but our results would apply to many other statistics.
The ultimate aim underlying most “screening studies” is to identify the largest
effects, and attribute them to specific markers or sets of markers. However screening
studies tend to be modestly powered, and strict control for multiple testing may
result in most of the dataset “uninteresting”. For example, the familywise error rate
(FWER) procedures (such as the Bonferroni correction) controls the probability of
making even one false positives in the multiple testings at level α. Then only a small
list of markers having the strongest effects are identified though the probability of
false positives is really low. An alternative approach, False Discovery Rate controlling
procedures are designed to control the expected proportion of false positives in a set of
findings (i.e. markers for which the null hypothesis could be rejected). Then a larger
list of markers are identified than the the familywise error rate procedures at the cost
of a given proportion of the markers in the list are false positives. If we increase the
number of markers in the list to be identified as interesting, then the proportion of
the markers in the list to be false positives is also increasing. Finally if we choose the
whole set of markers, then the proportion of the markers to be false positives equals
one minus the proportion of markers having large effects (true positive). Therefore
estimating the proportion of markers having large effects in one or two subpopulations
without attributing them to specific markers is our main interest. In this paper, we
use correlation coefficients ρi as the effect sizes, we will estimate the distribution of
the effect sizes F and the proportion of the magnitude of the effect sizes ρi greater
than some threshold t.
An effect size is a measure of the strength of the relationship between two vari-
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ables in a statistical population, or a sample-based estimate of that quantity. it is
commonly used in genome-wide association studies, and there are different types of
effect sizes used by researchers, like Pearson r correlation, effect sizes based on means
(Cohen’s d, Glass’s ∆) and odds ratios (Hedges and Olkin (1985)). Effect sizes often
refer to a statistic calculated from a sample of data, and are usually estimated with
error and may be biased. If many researchers are carrying out studies under low sta-
tistical power, the reported effect sizes are biased to be stronger than the true effects
(A et al. (2008)). Many researchers report the estimates of effect sizes in genome-wide
association studies and the empirical distributions of the significant effect sizes (Nak-
agawa and Cuthill (2007), Park et al. (2011)), but fewer of them focus on reducing
the bias of the estimate and the true effect sizes and the distribution of the true effect
sizes and even fewer of them focus on the overlap of the true effect sizes in multiple
subpopulations.
Here we focus on a situation that commonly arises in practice, where the units of
analysis are not homogeneous, and are structured into groups derived from different
subpopulations. Specifically, we have a sample of subjects with chronic kidney disease,
each subjects has one of nine underlying diseases that resulted in the kidney disease.
In this situation, it is often of interest to consider the fraction of markers having
large effect sizes in any given subpopulation and the fraction of markers having large
effect sizes in specific pairs of two subpopulations. That is, we ask whether the
number and strength of marker/outcome relationships are similar in the different
subpopulatons, and whether the strongest predictors are common or unique across
different subpopulations.
This task is made more challenging by the fact that statistical power is uneven
among the subpopulatons. Thus, even if the number of relationships of a given effect
size in two subpopulations are similar under FWER or FDR procedures, the better
powered subpopulation will show a greater number of associations. However effect
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size ρi is invariant to statistical power, then it is used in this chapter to represent the
marker/outcome relationship.
3.2 Measures of strength and overlap of effects
Here we view the effect sizes ρi = Cor(Y,Xi), the Pearson correlation coefficients
between the outcome and ith marker, to be a random variable having a univariate
distribution function F . Based on F , we can define a measure for a given threshold
t > 0 as the fraction of markers with effect size magnitude (e.g. true correlation
coefficient) equal to or exceeding t in one population:
N1(t) = P (|ρ| > t) = 1− F (t) + F (−t).
This measure N1(t) represents the strength of marker/outcome relationships, as larger
values of N1(t) represent stronger relationships.
If we have two subpopulations A and B, let ρAi and ρ
B
i denote the population
associations for the ith marker and the outcome in subpopulations A and B. Then the
set of paired values (ρAi , ρ
B
i ) can be described with a bivariate distribution function
FAB. Based on FAB, we can define an overlap measure for a given threshold t > 0
as the fraction of markers with effect size magnitude equal to or exceeding t in both
subpopulations:
N2(t) = P (|ρA| > t, |ρB| > t)
= FAB(−t,−t) + 1− (FAB(t,∞) + FAB(∞, t)− FAB(t, t)). (3.1)
Similar with N1(t), N2(t) represents the strength of marker/outcome relationships in
both subpopulations.
Since we cannot observe the true effect sizes ρi, we work with the observed ef-
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fect sizes ρ̂i = Ĉor(Y,Xi), where Xi = (Xi1, · · · , Xin). There is a estimation error
ϵ between ρ and ρ̂, where ϵ approximately has a normal distribution with standard
deviation 1
n
. This is motivated by the fact that over a large class of data generat-
ing distributions for the underlying independent paired data,
√
nρ̂ is asymptotically
standard normal. Here is the sampling error model:
ρ̂i = ρi + ϵi, (3.2)
where ϵi ∼ N(0, 1n).
Usually we will transform the correlation coefficient ρ to a variance stablized









and vary approximately with a normal distribution around their cental value. We
can write
Zi = θi + ηi,









is an approximate relationship between θi and our true effect sizes ρi. Now we focus
on the standardized parameter θi and the standardized statistic Zi instead of the true
effect size ρi and the estimated effect size ρ̂i, since θi and Zi are standardized and have
invariant variances with different ni, which is the number of subjects in subgroup i.
Then it is more convenient to estimate the distribution of the standardized parameter
θi than the distribution of the true effect sizes ρi. Also it is sufficient to measure







For two subpopulations A and B, (ρA, ρB) are the population correlation coeffi-
cients between markers and outcome in subpopulaton A and B. The variance stablized
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i ) are the
variance stablized standardized parameters in two subpopulations A and B, and it
is more convenient to estimate the bivariate distribution of the pairs of parameters
(θAi , θ
B
i ). Then it is sufficient to estimate R2(t1, t2) = P (|θA| > t1, |θB| > t2) instead











3.2.1 Plug-in estimation of effect size summaries
The most common and direct way to estimate R1(t) is just to use the standardized






to substitute F when plugging into R1(t). This is R̂1(t) called the plug-in estimate
of R1(t), which can be substantially biased.
From the sampling error model, we know the distribution of Zi is the convolution
of the distribution of θi and a standard normal distribution. The bias of R̂1(t) is
easily seen to be related to the shape of F . The bias is small when F is diffuse.
For example, if F is a uniform distribution, there is no bias since f ⋆ ϕ ≈ f when
f ∼ Unif(−a, a) for large a. The bias is large when F is concentrated near zero. For
example, if f is a point mass at zero, then f ⋆ ϕ is a normal distribution whose tail
probabilities differ strongly from those of f .
For two subpopulations A and B, the plug-in estimator R̂2(t1, t2) is calculated by




I(ZAi < t1 & Z
B
i < t2)/m
to R2(t1, t2). The direction of bias in R̂2(t1, t2) is difficult to anticipate. The standard-
ized statistics (ZA, ZB) are more dispersed than their true standardized parameters
(θA, θB). This will bias R2(t1, t2) upward. But (ZA, ZB) will be less dependent than
(θA, θB). This will bias R2(t1, t2) downward.
3.2.2 Illustration of bias in plug-in estimates
We present some examples to highlight how the bias in the plug-in estimate of
R2(t1, t2) occur. Figure 3.1a depicts one extreme situation, where the true (ρ
A, ρB)
values cluster just below the threshold value t, as depicted in the darker grey color.
The lighter grey color depicts the observed distribution of (ρ̂A, ρ̂B) values. In this
extreme case, all the true parameters fall just outside the region of interest (the set
of points x,y such that min(x, y) ≥ t), while up to half of these estimated points are
extended to fall inside the region of interest. Figure 3.1b shows a contrasting extreme
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Figure 3.1: Schematic example showing positive bias (a) and negative bias (b) be-
tween the observed and true proportions of association statistics in a re-
gion of interest. The distribution of true statistics is shown in the darker
color, and the distribution of observed statistics is shown in the lighter
color. The region of interest is (x, y : min(x, y) ≥ t).
situation, where all the true parameters lie inside the region of interest, but up to
three quarters of the estimated parameters are expected to lie outside it.
Figure 3.2 and 3.3 are two realistic examples from the CKD data described in
section 1.2 of the thesis. The standardized statistic Zi is the fisher transformation
of the sample correlation coefficient ρ̂i between each marker and the outcome GFR
for different disease subgroups. The right plots of figure 3.2 and 3.3 are the scatter-
plots of the standardized statistics (ZAi , Z
B
i ) for disease subgroups (MCD, LD) and
(IgA, Pima). Though we do not know the true standardized parameter θi for disease
subgroups, we could estimate them using the methods I will discuss later. Assume
the estimate of the true standardized parameter θ̂i is known, the left plots of figure
3.2 and 3.3 are the scatterplots of the estimate of the true standardized parameters
(θ̂Ai , θ̂
B
i ) for disease subgroups (MCD, LD) and (IgA, Pima).








I{|ZAi |>t1 & |ZBi |>t2}/m.
Also we could estimate R2(t1, t2) using the estimate of the true standardized param-
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Figure 3.2: Left is the scatterplot of the estimated standardized parameters θAi , θ
B
i for
disease subgroups MCD, LD; right is the scatterplot of the standardized
statistics ZAi , Z
B
i for disease subgroups MCD, LD.
Figure 3.3: Left is the scatterplot of the estimated standardized parameters θAi , θ
B
i for
disease subgroups IgA, Pima; right is the scatterplot of the standardized
statistics ZAi , Z
B
i for disease subgroups IgA, Pima.






I{|θ̂Ai |>t1 & |θ̂Bi |>t2}
/m.
Figure 3.2 shows R̃2(1, 1) = 0.15 and R̂2(1, 1) = 0.17. There is not much differ-
ence between R̃2(1, 1) and R̂2(1, 1) in this situation, because the estimate of the true
standardized parameters (θAi , θ
B
i ) in disease subgroups IgA and Pima are highly cor-
related with r = 0.7, then the standardized statistics (ZAi , Z
B
i ) are less dependent
than (θAi , θ
B





more dispersed than (θAi , θ
B
i ) which will bias the measure up.
Figure 3.3 shows R̃2(1, 1) = 0.0 and R̂2(1, 1) = 0.06. It appears that there is little
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correlation of the estimate of the true standardized parameters (θAi , θ
B
i ) between MCD
and LD disease subgroups, since LD is the control group of people who do not have
kidney disease which is irrelevant to other disease subgroups in CKD data. The




i ) will be more dispersed
than (θAi , θ
B
i ) but the dependencies will remain the same.
3.3 Approaches to bias reduction of the estimation of the
effect size summaries
In order to estimate R1(t) and R2(t1, t2) without much bias, we need to first
estimate univariate distribution function F (or FAB for two subgroups) by considering
the effects of the sampling error ηi on standardized sample statistics Zi. Estimating F
based on noisy observations with known error distribution is the well-studied “density
deconvolution” problem.
We have two general ways to estimate the distribution of the true standardized
parameters (θAi , θ
B
i ). One is parametric way if we know the statistical model of the
distribution, like normal distribution, t distribution and here we will also introduce
two ways to estimate the unknown parameters of the distribution, which are moment
estimates and maximum likelihood estimates. The other way to estimate the dis-
tribution is nonparametric way if we have no idea about how the distribution looks
like. Here we also introduce two ways, rescaling method and copula method. In the
following paper, we will discuss the advantages and disadvantages of all these meth-
ods provided with different distributions of the true standardized parameters θ both
in univariate and multivariate cases and simulation results are given. Then we will




If the framework of the distribution F is known with parameter αj, j = 1, · · · , k,
k is the number of parameters need to be estimated. Then the first k moments of θ
would be:
µ1 = E[θ
1] = g1(α1, · · · , αk),
µ2 = E[θ
2] = g2(α1, · · · , αk),
...
µk = E[θ
k] = gk(α1, · · · , αk),





the jth sample moment corresponding to the population moment µj, the method of
moments estimator for α1, · · · , αk denoted by α̂1, · · · , α̂k is defined by the solution to
the equations:
µ̂1 = g1(α̂1, · · · , α̂k),
µ̂2 = g2(α̂1, · · · , α̂k),
...
µ̂k = gk(α̂1, · · · , α̂k). (3.3)
Since g1, · · · , gk is known, to get the moment estimates α̂1, · · · , α̂k of α1, · · · , αk, we
need to estimate the sample moments µ̂1, · · · , µ̂k. From the sampling error model,
we know θi = Zi − ηi and η̄i = 0, V̂ ar(ηi) = 1, ηi is independent with θi. Then the




























· · · . (3.4)
Then by plugging into the value of µ̂1, · · · , µ̂k to equations 3.3, α̂1, · · · , α̂k could be
solved.
Here we will introduce generalized normal distribution as an example of the dis-
tribution F . Generalized normal distribution is a family of continuous probability
distribution in which the shape parameter can be used to introduce skew. When
the shape parameter is zero, the normal distribution results. Positive values of the
shape paramter yield left-skewed distribution bounded to the right, and negative val-
ues of the shape parameter yield right-skewed distributions bounded to the left. Its










] if κ ̸= 0.
ϕ is the standard normal pdf, x ∈ (−∞, ξ + α/κ) if κ > 0; x ∈ (−∞,∞) if κ = 0;
x ∈ (ξ + α/κ,∞) if κ < 0. The functions g1, · · · , g3 are











2 − 1) + g21,
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2 − e3κ2 − 2)
κ3
sign(κ) + 3g1g2 − 2g31.
Then if we could calculate the values of µ̂1, · · · , µ̂3 using the sample standardized
statistics Zi by equations 3.4 and use the functions g1, · · · , g3 above, α̂, κ̂, ξ̂ could be
estimated using equations 3.3.
3.3.1.2 Maximum Likelihood estimate
As we all know maximum-likelihood estimation (MLE) is a method of estimating
the parameters of a given statistical model. In general, for a fixed set of data and
underlying statistical model, the method of maximum likelihood selects values of
the model parameters that produce a distribution that gives the observed data the
greatest probability (i.e. parameters that maximum the likelihood function). Here we
have observed statistic {Zi}, and if we know the density function of true parameter
{θi} is f(θ, α), α = (α1, · · · , αk), using sampling error model, we know the density
function for {Zi} is g(Z, α) = f(θ, α)∗ϕ, the convolution of f and a standard normal
density. The likelihood function is




In normal and many other cases, if the statistical model is known, the method of
moments and MLE method would be the most simple and quick way to estimate the
parameters of the distribution function F of our true parameters θ and then estimate
the measure of the fraction of the markers with effect size magnitude greater than
some threshold in one population R1(t).
For two subpopulations A and B, if the bivariate distribution FAB of the true pa-
rameters θA, θB is known with parameter (α, β, r), α = (α1, · · · , αk), β = (β1, · · · , βk).
We could still use moments method and MLE method to estimate the parameters of
the bivariate distribution FAB and then estimate the overlap measure of the fraction
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of the markers with effect size magnitude both greater than some threshold t in two
subpopulations R2(t1, t2). Here we use bivariate normal distribution as an example
of FAB in two subpopulations A, B. Then the probability density function for true
























where r is the correlation between θA and θB and σA > 0, σB > 0. Then the


























σ2A + 1, σ̃B =
√
σ2B + 1. Then the likelihood function for the observed
standardized statistics (ZA, ZB) is







i ;µA, µB, σA, σB, r). (3.7)
The parameters µA, µB, σA, σB and r of the bivariate normal distribution FAB could
be estimated by maximizing the likelihood function L(ZA, ZB;µA, µB, σA, σB, r).
For moment estimators of µA, µB, σA, σB and r of the bivariate normal distribution




i ). First we know the
relationships between the parameters µA, µB, σA, σB, r and the first and second
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moments of FAB:












r = cor(θA, θB) = cov(θA, θB)/(sd(θA) ∗ sd(θB)). (3.8)
Second we could estimate the sample moments of FAB using the observed standard-
ized statistics ZAi , Z
B




i − θAi , ηBi = ZBi − θBi ,
i = 1, · · · ,m. As noted above, basic asymptotic theory suggests treating ηA|θA as
following a standard normal distribution. If we view θA as random, ηA is uncondition-
ally standard normal. We also assume that ηA and θA are independent. A parallel


































i /m = 0. (3.9)


















































































ˆCov(ZA, ZB) = ˆCov(θA + ηA, θB + ηB) = ˆCov(θA, θB). (3.10)















































r̂ = ˆcor(θAi , θ
B







If we do not know the statistical model of the true standardized parameters
(θA, θB), there is a method called “Rescaling method” may help estimate R1(t) and
R2(t1, t2). The basic idea of rescaling method is to produce two sets of points whose
sample variance, and sample mean are the same with true parameters (θA, θB) and
the correlation of these two sets of points is the same with the correlation between
true parameters (θA, θB). This will give us two sets of points whose dispersion and
degree of association are comparable to the true standardized parameters θA and θB
values. The empirical distribution function of these points, denoted as F̃AB will be
plugged into R1(t) and R2(t1, t2).
We could calculated the sample variance σ̂2A, σ̂
2
B, sample mean µ̂A, µ̂B and sample
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r̂ = ˆcor(θAi , θ
B





For univariate case, we have the transformed statistics
Z̃ = λ1Z + λ2, (3.12)
where λ1 ranges from -1 to 1 is set to meet the desired variance σ̂
2 and then choose
λ2 which will not effect the variance of Z̃ to meet the desired mean value µ̂. Once Z̃
is generated, the rescaling estimate of R1(t) = P (|Z̃| > t).
For bivariate case, we have the transformed statistics
Z̃A = λA1(ZA + λrZB) + λA2 ,
Z̃B = λB1(ZA + λrZB) + λB2 . (3.13)
Note that as λr ranges from -1 to 1, the correlation coefficient between Z̃A and Z̃B
ranges from -1 to 1 monotonically. Thus there is always a unique value of λr such
that the correlation between Z̃A and Z̃B equals r̂. This value can easily be found
numerically using bisection computing method. Once this value, λr̂, is found, the





and λA2 , λB2 are set to give the desired mean µ̂A, µ̂B. Once Z̃A, Z̃B are generated,
the rescaling estimate of R2(t1, t2) = P (|Z̃A| > t1, |Z̃B| > t2).
We note that this approach is exact for large samples if FAB is approximately
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Gaussian. If the exact values of r, σA, σB are used rather than the estimates, the
(ZAi , Z
B
i ) pairs can be linearly transformed to the exact joint distribution of (θ
A, θB).




) values will in general not
be exactly distributed according to FAB, even if r, σA, σB are estimated exactly.
3.3.2.2 Copula method
If we specify a parametric statistical model FAB for the joint distribution of the
true standardized parameters (θAi , θ
B
i ), we could use the MLE or method of moments
to estimate the parameters of FAB. As a more general approach, we can follow the













i ) are centered bivariate normal random variables,
with SD(XAi ) = SD(X
B




i ) = r, and tA, tB are non-decreasing
real-valued functions of a real variable.
To review, the basic idea of a copula is that we consider a random vector (Y1, · · · , Yd).
Suppose its marginal CDFs F1, · · · , Fd are continuous functions. By applying the
probability integral transform to each component, the random vector
(U1, · · · , Ud) = (F1(Y1), · · · , Fd(Yd))
has uniform margins. The copula of (Y1, · · · , Yd) is defined as the joint cumulative
distribution function of (U1, · · · , Ud),
C(u1, · · · , ud) = P [U1 ≤ u1, · · · , Ud ≤ ud].
The copula C contains all information on the dependence structure between the com-
ponents of (Y1, Y2, · · · , Yd) whereas the marginal cumulative distribution functions Fi
contain all information on the marginal distributions. The importance of the above
is that the reverse of these steps can be used to generate random samples from gen-
55
eral classes of multivariate probability distributions. That is, given a procedure to
generate a sample (U1, U2, · · · , Ud) from the copula distribution, the required sample
can be constructed as
(Y1, Y2, · · · , Yd) = (F−11 (U1), F−12 (U2), · · · , F−1d (Ud)).
The inverses F−1i are unproblematic as the Fi were assumed to be continuous. The
above formula for the copula function can be rewritten to correspond to this as:
C(u1, · · · , ud) = P [Y1 < F−11 (u1), · · · , Yd < F−1d (ud)]
Here we use the Gaussian copula by projecting a multivariate normal distribution
on Rd by means of the probability integral transform to the unit cube [0, 1]d. For a
given correlation matrix Σ, the Gaussian copula is
CGaussΣ (u) = ΦΣ(Φ
−1(u1), · · · ,Φ−1(ud)),
where Φ−1 is the inverse cumulative distribution function of a standard normal distri-
bution and ΦΣ is the joint cumulative distribution function of a multivariate normal




−1F (Y1), · · · , Xd = Φ−1(ud) = Φ−1F (Yd), (3.14)
then X1, · · · , Xd follows a joint multivariate normal distribution with mean vector
zero and covariance matrix equal to the correlation matrix Σ.
In this paper, we focus on estimating the joint distribution of the true standardized
parameters (θAi , θ
B











then (XAi , X
B
i ) follows a bivariate normal distribution with E(X
A
i ) = E(X
B
i ) = 0,
SD(XAi ) = SD(X
B
i ) = 1, and correlation matrix Σ =
1 r
r 1






Also in our analysis, we cannot use the standard copula, because we are seeking
to model the joint distribution of (θAi , θ
B
i ), which are not observed. Therefore, we
extend the basic copula idea as follows. Since we do not observe θAi and θ
B
i , we
cannot simply compute their empirical distribution functions FA, FB and quantile
functions. We therefore model tA = Φ
−1FA and tB = Φ
−1FB as continuous linear





































i ) ⋆ ϕ, (3.16)
where ϕ represent a standard bivariate normal distribution with correlation matrix
I, can be easily computed numerically. We then optimize the joint log likelihood
function of the standardized sample statistics ZA, ZB,
L(tA, tB, r;ZA, ZB) =
m∑
i=1







i ) ⋆ ϕ]. (3.17)
over tA, tB and the correlation parameter r.
our approach for optimizing 3.17 is heuristic, and employs a greedy stochastic op-
timization. We first define a grid Gr on [−1, 1], and for each r ∈ Gr, we optimize 3.17
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over (tA, tB). The optimization over (tA, tB) are conducted by generating random
non-decreasing sequences D, and first setting
t
(i+1)





B , where λ initially is set at λ = 0.5, and is successively halved until a higher









B , r;ZA, ZB).
If no such value is reached, the function of tA at the (i + 1)





A . Second set
t
(i+1)





A , where λ initially is set at λ = 0.5, and is successively halved until a









B , r;ZA, ZB).
If no such value is reached, the function of tB at the (i + 1)





B . A random non-decreasing sequences D is generated in each iteration and








B = I. Then




B , r;ZA, ZB) for each correlation
parameter r ∈ Gr and report the value of r that optimize the log likelihood value





The sequence D is generated by first simulate k i.i.d. values {U1i} uniformly on
[−mx1,mx2], where mx1,mx2 are values uniformly distributed on [−10, 10] and k is
the number of values in {U1i}, which is a random integer from 3 to 20. Then simulate
k i.i.d. values {U2i} uniformly on [mx3,mx4], where mx3,mx4 are the minimum and
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maximum values of observed standardized statistic Zi and k is a random integer from
3 to 20. Then sequences {U1i} and {U2i} are sorted from low to high and there is
a function Fu mapping {U2i} to {U1i} and any two adjacent values (U1i, U1,i+1) are
connected linearly. We construct a grid G on [mx3,mx4] with 200 knots, then the
sequence D = Fu(G).
3.4 Simulation study for univariate analysis
First, we focus on the univariate analysis. We will estimate the marginal dis-
tribution of the standardized parameter θ, and then estimate R1(t) when the true
marginal distribution of θ has three situations. We will compare the results of the
plug-in estimates, moment estimates, mle estimates, rescaling estimates and copula
estimates of R1(t) with the true value of R1(t). The following are the simulation
steps:
1. Generate true standardized parameter θi, i = 1, · · · ,m, m = 10000 from a
given distribution F , F has three situations illustrated above, i): N(0, 1),
(ii): t distribution with df = 3 (iii): generalized normal distribution with
ξ = −0.5, α = 2, κ = −0.5. Then generate a sequence of theresholds T vary from
0 to 4 by 0.2 and the true value of R1(T ) is calculated by R1(t) =
∑m
i=1 I|θi|>t/m
for every t in T .
2. The observed standardized statistic Zi is estimated by adding standard normal
errors to θi, Zi = θi + ηi, ηi follows standard normal distribution. Then the
plug-in estimator of R1(T ) is calculated by R1(t) =
∑m
i=1 I|Zi|>t/m for every t
in T .
3. If we assume that F is a normal distribution with mean µ and standard deviation
σ, no matter what the true distribution F is. The moment estimator of R1(T )
is calculated by estimating the parameters of the distribution F by matching
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the first 2 moments of the distribution F to the first 2 sample moments of θ.
















4. The mle estimator of R1(T ) is calculated by estimating the parameters of the












which is the convolution of the density function of θ and a standard normal






5. The rescaling estimator of R1(T ) is calculated by transforming the observed
statistic Z to a new vector X which has the same mean and variance with the
true parameter θ by using equation 3.12, then R1(T ) is calculated by R1(t) =∑n
i=1 I|Xi| > t/n for every t in T .
6. The copula estimator of R1(T ) for univariate analysis is just focusing on how to
estimate the monotone increasing functions t that maps the true parameters θ
to a random variable X which follows a standard normal distribution using the
linear spline method we introduced in section 3.2.2. Once t̂ is the estimated,
we could construct a sample of values X with sample size n = 10000 from a
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Figure 3.4: Plots of the true R1(t) and the average of the estimate of R1(t) for each
parametric and nonparametric methods when the true marginal distri-
bution is N(0, 1) and the grey area is the approximate 95% confidence
intervals for the estimate of R1(t).
standard normal distribution, and then construct a sample of estimated param-
eters θ by θ̃ = t−1(X). Then the copula estimator of R1(T ) is calculated by
R1(t) =
∑m
i=1 I|θ̃i|>t/n for every t in T .
7. The procedure was repeated 100 times to get the average value and the standard
deviation of the estimate of R1(T ) for each method. The plots comparing the
true R1(t) and the average of the estimate of R1(T ) and the approximate 95%
confidence intervals for the estimate of R1(t) for each method is constructed.
Figure 3.4 shows the situation when the true parameters θ follows a standard
normal distribution, all the methods except the plug-in method perform the same,
all the estimates of the R1(T ) are very close to the true value of R1(T ) and have
very small variation. Since the parametric model of the marginal distribution of θ
for moments and mle method is the same with the true marginal distribution of θ
and the variance of the true parameters θ is fairly large, then the moment and mle
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Figure 3.5: Plots of the true R1(t) and the average of the estimate of R1(t) for each
parametric and nonparametric methods when the true marginal distribu-
tion is t(3) and the grey area is the approximate 95% confidence intervals
for the estimate of R1(t).
Figure 3.6: Plots of the true R1(t) and the average of the estimate of R1(t) for each
parametric and nonparametric methods when the true marginal distribu-
tion is generalized normal distribution with ξ = −0.5, α = 2, κ = −0.5
and the grey area is the approximate 95% confidence intervals for the
estimate of R1(t).
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method perform well. So do the rescaling and copula method.
Figure 3.5 shows the situation when the true parameters θ follows t distribution
with df = 3, then the parametric estimates of R1(T ) which assume the normal model
of the distribution of θ are biased. While the copula method give a more accurate
estimate than the other methods but with more variabilities.
Figure 3.6 shows the situation when the true parameters θ follows a generalized
normal distribution with ξ = −0.5, α = 2, κ = −0.5, now the distribution of θ is not
symmetric, then the parametric estimates of R1(T ) which assume the normal model
of the distribution of θ show much deviation from the true R1(T ), and perform even
worse than the plug-in estimates, while the copula method perform the best.
As a conclusion, the copula method for univariate analysis performs the better
than the other method if the distributions of the true standardized parameter θ is
not normal. Then we will look at whether this conclusion is also true for bivariate
analysis.
3.5 Simulation study for bivariate analysis
Now, we focus on the bivariate analysis. We will estimate the bivariate distribu-
tion FAB of the standardized parameters (θA, θB) for two subgroups A, B, and then
estimate R2(t, t) when the true bivariate distribution is known. We will compare the
results of the plug-in estimates, moment estimates, mle estimates, rescaling estimates
and copula estimates of R2(t, t) with the true value of R2(t, t). The following are the
simulation steps:
1. Generate scores XAi , X
B
i , i = 1, · · · ,m, m = 10000 from a bivariate normal
distribution with mean vectors 0 and correlation matrix Σ =
1 r
r 1
, r = 0 or
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i ) follows stan-





i follows marginal t distribution with df = 3 and when they
are transformed back to XAi , X
B
i using function tA, tB, they have correlation





generalized normal distribution with ξ = −0.5, α = 2, κ = −0.5 and when they
are transformed back to XAi , X
B
i using function tA, tB, they have correlation r.
Then generate a sequence of theresholds T vary from 0 to 4 by 0.2 and the true
value of R2(T, T ) is calculated by R2(t, t) =
∑m
i=1 I{|θAi |>t & |θBi |>t}/m for every
t in T .
2. The observed standardized statistics (ZAi , Z
B
i ) are estimated by adding standard














where (ηAi , η
B
i ) follows independent standard normal distribution. Then the
plug-in estimator ofR2(T, T ) is calculated byR2(t, t) =
∑m
i=1 I{|ZAi |>t & |ZBi |>t}/m
for every t in T .




i ) is bivariate normal with
parameters µA, µB, σA, σB, r, the moment estimator of R2(T, T ) is calculated
by estimating the parameters of the distribution FAB by matching the first 2






the sample correlation between θAi and θ
B

































r̂ = ˆCov(ZAi , Z
B
i )/(σ̂Aσ̂B).
Then we could generate samples (X̃A, X̃B) from this bivariate normal distribu-
tion with parameters µ̂A, µ̂B, σ̂A, σ̂B, r̂. Then the moment estimator of R2(T, T )
is calculated by R2(t, t) =
∑m
i=1 I{|X̃Ai |>t & |X̃Bi |>t}/m for every t in T .
4. With the same assumption of step 3, The mle estimator of R2(T, T ) is calculated
by estimating the parameters of the distribution FAB by maximizing the like-
lihood density function of the observed standardized statistic (ZAi , Z
B
i ), which
is the convolution of the density function of (θAi , θ
B
i ) and a standard normal
density function from equations 3.7. Once the parameters µ̂A, µ̂B, σ̂A, σ̂B, r̂ are
estimated using the mle method, we could generate samples (X̃A, X̃B) from this
bivariate normal distribution with parameters µ̂A, µ̂B, σ̂A, σ̂B, r̂. Then the mle
estimator of R2(T, T ) is calculated by R2(t, t) =
∑m
i=1 I{|X̃Ai |>t & |X̃Bi |>t}/m for
every t in T .
5. The rescaling estimator of R2(T, T ) is calculated by transforming the observed
statistic (ZA, ZB) to a new vector (XA, XB) which has the same mean and
variance with the true parameter (θA, θB) and the correlation between (XA, XB)
should equal to the correlation between (θA, θB) by using equation 3.13, then
R2(T, T ) is calculated by R2(t, t) =
∑n
i=1 I{|XAi |>t & |XBi |>t}/n for every t in T .
6. The copula estimator of R2(T, T ) is calculated by estimating the functions tA,
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tB, which maps the true standardized parameters (θA, θB) to (XA, XB), and
(XA, XB) follows a standard bivariate normal distribution with correlation r.
The functions tA, tB could be constructed using the method in section 3.2.2 if
we do not know the model of the joint distribution of (θA, θB). Once t̂A, t̂B, r
are estimated, generate large samples (XAi , X
B
i ), i = 1, · · · , n, n > m from a
standard bivariate normal distribution with correlation r̂. Then the samples of








The copula estimate ofR2(T, T ) is calculated byR2(t, t) =
∑n
i=1 I{|θ̃Ai |>t & |θ̃Bi |>t}
/n
for every t in T .
7. The procedure was repeated 100 times to get the average value and the standard
deviation of the estimate of R2(T, T ) for each method. The plots comparing
the true R2(T, T ) and the average of the estimate of R2(T, T ) and the approxi-
mate 95% confidence intervals for the estimate of R2(T, T ) for each method are
constructed.
From figure 3.7 and 3.8, we know that when the true parameters (θAi , θ
B
i ) follow
a bivariate normal distribution, the moment, mle and rescaling method perform the
best with unbiased estimates of R2(T, T ) and smaller standard deviations of the
estimates. This is because the parametric model we use for the joint distribution
of (θAi , θ
B
i ) for moments and mle method is the same with the true model. Also we
know that rescaling method performs well for Guassion cases. Copula method which
does not depend on the structure of the joint distribution performs a little worse with
a little more bias of the estimate of R2(T, T ) and more standard deviations of the
estimates. The plug-in estimator performs the worst.
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From figure 3.9-3.12, we know that when the true parameters θAi , θ
B
i follows a
marginal t distribution with df = 3 or the true parameters θAi , θ
B
i follows a marginal
generalized normal distribution, the copula method gives the smallest bias of the
estimate of the R2(T, T ) to the true values of R2(T, T ) than the other estimators,
especially on the tail (when the true proportion is less than 0.1). Since the true joint
distribution of (θAi , θ
B
i ) is not bivariate normal anymore, then the moment estimator,
mle estimator and rescaling estimator perform bad. As a conclusion, If the joint
distribution of the true standardized parameter (θAi , θ
B
i ) is much deviated from bi-
variate normal distribution, the copula method performs much better than the other
parametric or nonparametric methods we illustrated in this paper.
3.6 Real data analysis
Here we propose our new copula-based method to estimate the common and
unique associations in CKD data set which was introduced in section 1.2. The ge-
nomic data in the CKD dataset consist of microarray measurements of gene expression
on specific cell types obtained from kidney tissue biopsy specimens taken early in the
disease course. The main clinical parameter of interest is the GFR taken at the biopsy
time. GFR is a widely used overall index of kidney function. Specifically, it estimates
how much blood passes through the tiny filters in the kidneys, called glomeruli, each
minute. Normal GFR results range from 90-120 mL/min, GFR below 60 mL/min im-
plies moderate loss of renal function, and GFR below 30 mL/min is considered to be
severe. The dataset includes genomic and clinical data for 195 subjects, and the gene
expression data quantify gene expression for 12,023 distinct genes or transcripts. The
subjects have one of several diseases that give rise to CKD. The diseases in the CKD
dataset include DN, LD, MCD, HT, RPGN, IgA, PIMA, SLE, FSGS, here LD is a
control group of people who are healthy. Our interest is to identify marker/outcome
associations both within and across disease subgroups.
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Figure 3.7: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a bivariate normal distri-
bution with mean 0 and std 1.0 and correlation 0. The lower right plot
compare the true function tA (red) with the estimated function t̂A (orange)
for copula method. Grey area is the approximate 95% confidence intervals
for the estimators of R2(T, T ), x axis is the true standardized parameter
θA, y axis is the transformed standard normal vector XA = tA(θA).
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Figure 3.8: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a bivariate normal distri-
bution with mean 0 and std 1.0 and correlation 0.5. The lower right plot
compare the true function tA (red) with the estimated function t̂A (orange)
for copula method. Grey area is the approximate 95% confidence intervals
for the estimators of R2(T, T ), x axis is the true standardized parameter
θA, y axis is the transformed standard normal vector XA = tA(θA).
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Figure 3.9: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a marginal generalized
normal distribution with parameters ξ = −0.5, α = 2, κ = −0.5 with
correlation 0.0. The lower right plot compare the true function tA (red)
with the estimated function t̂A (orange) for copula method. Grey area is
the approximate 95% confidence intervals for the estimators of R2(T, T ),
x axis is the true standardized parameter θA, y axis is the transformed
standard normal vector XA = tA(θA).
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Figure 3.10: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a marginal generalized
normal distribution with parameters ξ = −0.5, α = 2, κ = −0.5 with cor-
relation 0.5. The lower right plot compare the true function tA (red) with
the estimated function t̂A (orange) for copula method. Grey area is the
approximate 95% confidence intervals for the estimators of R2(T, T ),x
axis is the true standardized parameter θA, y axis is the transformed
standard normal vector XA = tA(θA).
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Figure 3.11: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a marginal t distribution
with df = 3 with correlation 0.0. The lower right plot compare the true
function tA (red) with the estimated function t̂A (orange) for copula
method. Grey area is the approximate 95% confidence intervals for the
estimators of R2(T, T ), x axis is the true standardized parameter θA, y
axis is the transformed standard normal vector XA = tA(θA).
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Figure 3.12: Plots compare the true standardized parameters θAi , θ
B
i magnitude both
greater than a sequence of thresholds T, R2(T, T ) to the estimates of
R2(T, T ) for moments, mle, rescaling, copula and plug-in methods when
the true standardized parameters θAi , θ
B
i follow a marginal t distribution
with df = 3 with correlation 0.5. The lower right plot compare the true
function tA (red) with the estimated function t̂A (orange) for copula
method. Grey area is the approximate 95% confidence intervals for the
estimators of R2(T, T ),x axis is the true standardized parameter θA, y
axis is the transformed standard normal vector XA = tA(θA).
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A direct way to investigate this is to estimate Pearson correlation coefficients ρ̂i
between the ith marker and the outcome GFR based on available data, however, it
is very hard to detect any interesting markers due to the small sample size from
figure 3.13. Except for the subjects pooled together, we have 195 subjects which is
fairly large and powerful to detect many interesting markers, the sample sizes for
the disease subgroups individually are small. PIMA group has the largest number of
subjects, which is 45 and LD group has the smallest number of subjects, which is only
10. From the right panel of figure 3.13, we could see that there are many markers
detected from the false discovery rate analysis for the pooled group due to the large
sample size, but the standard deviation of the effect sizes ρi for the pooled group is
not the largest. However, RPGN disease subgroup has the highest standard deviation
of the effect sizes but not much information from false discovery rate analysis. LD
and DN disease subgroups have some effects while get nothing from false discovery
rate analysis.
Since effect sizes ρi is invariant with different sample sizes, we will focus on the
estimated correlation coefficient ρ̂Ai of subgroup A to a variance stablized standardized



















where ηAi is approximately normal and θ
A
i is the true variance stablized standard-
ized parameter. Now we are interested in estimating measure R1(t) = P (|θAi | > t)
and R2(t1, t2) = P (|θAi | > t1, |θBi | > t2). Once the fisher transformed standardized
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statistic ZAi for subgroup A is estimated from the real data set, we could use the
same procedure as the simulation steps in univariate analysis to calculate the mle
estimator, plug-in estimator and copula estimator of R1(T ) for a sequence of thresh-
olds T and the estimated marginal distribution of the true standardized parameter
θAi . For plug-in method, we just use the empirical distribution of the standardized
statistic ZAi as the marginal distribution of θ
A
i . For mle method, we could estimate
the parameters µA, σA of the estimated marginal distribution of θ
A
i , if we assume the
distribution is normal. For copula method, we could first estimate the nonparametric




i which follows standard normal distributions, then
since tA = Φ
−1F , where F is the marginal distribution of θAi , then F̂ = Φ(tA) is the
estimate of the marginal distribution of θAi .
Figure 3.14 is the plots of the plug-in estimate, mle estimate and copula estimate
of the CDF of true parameter θAi for all the disease subgroups A and the subgroups
pooled together. We could see that except for the pooled group, the mle estimate
and the copula estimate of the CDF of θAi are quite similar, implying that the true
marginal distribution of θAi is close to a normal distribution. Table 3.1 is the estimates
of R1(2) of the three methods for all the disease subgroups and the subgroups pooled
together. MLE estimator and copula estimator give similar result for most of the
disease subgroups except for the pooled group while the plug-in estimator always
bias up the true value of R1(2) since the sample statistic Z are always more dispersed
than the true parameter θ which will lead to higher proportion of markers having
effect sizes magnitude greater than some threshold t. Except for the pooled group,
disease subgroups IgA, PIMA have the highest proportion (above 0.2) of markers
having large effects, on the other side disease subgroups DN, MCD almost have no
markers having effect size magnitude greater than 2.
Now we estimate the overlap measure R2(T, T ). Once the fisher transformed
standardized statistic (ZAi , Z
B
i ) for each pair of disease subgroups A,B are estimated
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Figure 3.13: Right plot is a bar graph comparing results of false discovery rate analysis
and standard deviation of the effect sizes for disease subgroups in CKD
dataset; Middle plot is the bar graph of the number of subjects in disease
subgroups in CKD data; Left plot is the boxplots of the outcome GFR
in disease subgroups in CKD data.
Table 3.1: MLE, copula, plug-in estimate of R1(2) for different disease subgroups.
Disease subgroup MLE estimate Copula estimate Plug-in estimate
Pooled 0.620 0.446 0.651
LD 0.087 0.07 0.218
DN 0 0 0.059
MCD 0.005 0.004 0.118
HT 0.042 0.050 0.167
RPGN 0.142 0.096 0.268
IgA 0.210 0.202 0.274
PIMA 0.021 0.015 0.146
SLE 0.130 0.128 0.244
FSGS 0.172 0.229 0.295
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Figure 3.14: Plots of the estimated CDF of true parameters θ of mle, copula and
plug-in method for disease subgroups and pooled together.
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from the real data set, we could use the same procedure as the simulation steps
in bivariate analysis to calculate the mle estimator, plug-in estimator and copula
estimator of R2(T, T ) for a sequence of thresholds T . Table 3.2 is the estimate of
R2(2, 2) from copula-based method for each pair of disease subgroups and table 3.3,
3.4 is the estimate of R2(2, 2) from mle and plug-in method for each pair of disease
subgroups.
From the copula estimates in table 3.1 we see that there are 9.6% of the markers
having effect size magnitude greater than 2 in RPGN, 20.2% in IgA, 12.8% in SLE,
and 22.9% in FSGS. From table 3.2, we see that 9.1% of the markers both having
effect size magnitude greater than 2 in RPGN and IgA. Compare to the result in table
3.1, almost all the markers having effect size magnitude greater than 2 in RPGN also
have effect size magnitude greater than 2 in IgA. From table 3.2, we also see that
10.9% of the markers both having effect size magnitude greater than 2 in RPGN
and SLE. Compare to the result in table 3.1, almost all the markers having effect
size magnitude greater than 2 in RPGN also have effect size magnitude greater than
2 in SLE. From table 3.2, we see that 6.9% of the markers both having effect size
magnitude greater than 2 in RPGN and FSGS. Compare to the result in table 3.1, a
large proportion of the markers having effect size magnitude greater than 2 in RPGN
also have effect size magnitude greater than 2 in FSGS, but the proportion is lower
than IgA and SLE.
For SLE, 10.5% of the markers both having effect size magnitude greater than 2
in SLE and IgA, and 8.2% of the markers both having effect size magnitude greater
than 2 in SLE and FSGS. Then there is a larger proportion of markers having effect
size magnitude greater than 2 in SLE have effect size magnitude greater than 2 in
IgA than FSGS. In other words, there are more common associations in SLE and IgA
than those in SLE and FSGS. At last, 11.2% of the markers both having effect size
magnitude greater than 2 in FSGS and IgA, while 22.9% and 20.2% in each disease
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Table 3.2: Copula estimate of R2(2, 2) for different pairs of disease subgroups.
Copula estimate DN LD MCD HT RPGN IgA PIMA SLE FSGS
Pooled 0.084 0.005 0.017 0.023 0.163 0.197 0.017 0.142 0.152
DN 0.0 0.0003 0.019 0.031 0.034 0.003 0.011 0.046
LD 0.0 0.0 0.0 0.0 0.0 0.0 0.0
MCD 0.0 0.0 0.001 0.001 0.005 0.0
HT 0.035 0.052 0.001 0.046 0.044
RPGN 0.091 0.0 0.109 0.069
IgA 0.005 0.105 0.114
PIMA 0.004 0.001
SLE 0.082
Table 3.3: MLE estimate of R2(2, 2) for different pairs of disease subgroups.
MLE estimate DN LD MCD HT RPGN IgA PIMA SLE FSGS
Pooled 0.075 0.0 0.003 0.034 0.116 0.191 0.013 0.106 0.149
DN 0.0 0.001 0.027 0.043 0.052 0.01 0.042 0.045
LD 0.0 0.0 0.0 0.0 0.0 0.0 0.0
MCD 0.003 0.003 0.004 0.001 0.005 0.002
HT 0.032 0.029 0.004 0.032 0.034
RPGN 0.110 0.005 0.103 0.111
IgA 0.008 0.104 0.132
PIMA 0.006 0.009
SLE 0.104
subgroup. This means that only a half of the markers have large effects in both FSGS
and IgA.
3.7 conclusion and future direction
Many genomic studies involves large number of markers with small number of
subjects, then it is powerless to detect any single effect. Such studies often involve
populations that can be subdivided into several distinct subpopulations. Then we
focus on the effect sizes of the marker/outcome associations which is invariant to
the sample size and propose parametric and nonparametric methods to estimate the
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Table 3.4: Plug-in estimate of R2(2, 2) for different pairs of disease subgroups.
Plug-in estimate DN LD MCD HT RPGN IgA PIMA SLE FSGS
Pooled 0.147 0.019 0.065 0.125 0.219 0.228 0.069 0.197 0.237
DN 0.005 0.012 0.044 0.06 0.075 0.024 0.064 0.069
LD 0.002 0.005 0.007 0.009 0.002 0.009 0.010
MCD 0.012 0.023 0.024 0.012 0.024 0.03
HT 0.061 0.08 0.016 0.061 0.074
RPGN 0.106 0.021 0.094 0.119
IgA 0.029 0.113 0.121
PIMA 0.022 0.027
SLE 0.115
overall distribution of the effect sizes and the magnitude of effect sizes greater than
some thresholds both in univariate and bivariate populations. Especially, we pro-
posed a copula-based nonparametric method to estimate the overlap measure of the
magnitude of effect sizes both greater than some thresholds in two subpopulations.
In simulation study, we compare the accuracy of the estimate of the overlap mea-
sures through mle, moment, rescaling, copula and plug-in methods and find out that
if the joint distribution of the true standardized parameter (θAi , θ
B
i ) is much deviated
from bivariate normal distribution, the copula method performs better than the other
parametric or nonparametric methods. Then we apply copula-based, mle and plug-in
method to estimate the overlap measure of the common associations in each pairs of
disease subgroups in CKD data. MLE estimator and copula estimator give similar
result for most of the pairs disease subgroups, implying that the joint distribution of
the effect sizes in any two disease subgroups is close to bivariate normal distribution.
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CHAPTER IV
Statistical assessment of relationships between
marginal properties of variables and their external
correlations
4.1 Introduction
Modern medical studies often aim to identify genomic markers of individuals
in a population that are associated with an external (i.e. non-genomic) trait. In
hypothesis-generating research, these genomic markers must be identified from a large
pool of candidate markers, most of which are irrelevant. For example, researchers in
nephrology may be interested in identifying genes whose expression correlates with a
measure of renal performance, such as the glomerular filtration rate (GFR). Simple
statistics such as Pearson correlation coefficients or standardized group-wise mean
differences are often used in this setting to identify potentially interesting markers.
Screening analysis arise in many application areas, such as fraud detection (Chen
et al. (2004)), astronomy (Schreiber et al. (2002)), and biomarker research, but here
we will focus on applications in personalized medicine involving genomic markers.
Our setting is a screening study with n independent subjects, each of whom
is assessed for a quantitative outcome yi ∈ R (i = 1, · · · , n). In addition, each
subject is assessed for gene expression on a large number of genes, we will write
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Xij for the measured expression of gene j in subject i. For each gene j, we can
assess the association Aj between the expression levels of the gene and the out-
comes. For a given measure Assoc of association, e.g. Pearson correlation, we have
Âj = Assoc(y1, · · · , yn;X1j, · · · , Xnj). In a traditional “screening analysis”, the aim is
typically to identify a subset of markers that meet some level of statistical confidence
such as a family-wise error rate or false discovery rate.
In many research settings, statistical power is low due to sample size limitations.
Thus, while a few interesting markers may be found in a single study, there is often a
sense that the data have much more to reveal. In this chapter, we focus on approaches
for identifying global trends in the data that help us to understand what types of
associations may be present. We illustrate that this can be accomplished even when
the power is too low to attribute associations to specific variables.
Our main goal here is to ask whether properties of the marginal distributions
of genomic markers can be identified that are statistically related to the strengths
of their associations with the external trait. For our purposes, a property M is a
function of the marginal distribution of one or more genes. For example, Mj could
be the population mean of the jth marker. A property/marker/outcome association
is then any relationships between Mj and Aj.
Such relationships are completely empirical since association as measured by Pear-
son’s correlation is location and scale invariant, there is no mathematical reason that
a trend must exist between the marker/outcome correlations and the marginal prop-
erties of the markers. However, in genomic datasets, these trends often exist.
Some researchers have some related findings that genes with unique gene expres-
sion pattern may contain some useful information and of great interest. For example,
gene pairs that have a large number of mutually exclusive outlier cancer samples are
shown to be more likely involved in chromosomal translocations which are common
in cancer and may be causal in the progression of the disease using COPA (Cancer
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Outlier Profile Analysis) by MacDonald and Ghosh (2006). And Genes which have
high connectivity (i.e. ‘hub’ genes) within a weighted co-expression network are sig-
nificantly more likely to be essential for yeast viability demonstrated by Zhang and
Horvath (2005).
Since the property/marker/outcome associations can be explicitly computed, it
seems straightforward to assess whether these are somehow related. However, to
fully understand this relationship, several challenges must be overcome. First, since
the markers are highly correlated with each other and they all associate with the
same outcome, then the marker/outcome correlations are highly dependent. This
has the potential to bias the property/marker/outcome associations. We proposed
a simulation-based approach to detect the bias and variability of this estimated as-
sociation. A Second challenge is that there exist both monotone and non-monotone
associations between genomic markers and the outcome. The monotone associations
are largely captured by the Pearson correlation which has favorable statistical proper-
ties. However the non-monotone associations like u-shape association are not detected
by the Pearson correlation coefficient. We develop a way that decomposes an associ-
ation into a monotone component and a symmetric concave/convex component (plus
a residual function) to see which association is dominant.
The chapter is organized as follows. In section 4.2, we will introduce the five
marginal properties of the distribution of markers we are interested in including the
definitions of the statistical measures of them. In section 4.3, we will introduce the
quantile regression method we use to model the property/marker/outcome associa-
tions with the L1 goodness of fit. Then we will talk about the statistical properties
of the property/marker/outcome associations. At last, we will illustrate the method
that decomposing the associations into monotone components and symmetric con-
cave/convex components plus a residual function. In section 4.4, we show the sim-
ulation results for the properties of the property/marker/outcome associations. In
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section 4.5, we use an example of CKD dataset to show the quantile regression re-
sults of the property/marker/outcome associations and find out that skewness is the
most dominant property. And also we notice that monotone trends between GFR and
symmetric genes are more likely to happen than symmetric concave trends by decom-
posing the association into monotone and symmetric concave components. Section
4.5 is the conclusion and future challenges for this chapter.
4.2 Marginal properties of variables involved in external as-
sociations
Our overall goal is to relate the marker/outcome associations Aj to the properties
of the marginal distribution of markers Mj. This motivation builds on some standard
practices used when analyzing large-scale genomic data. For example, filtering meth-
ods (Hackstadt and Hess (2009)) are usually used to reduce the number of hypothesis
tests and therefore increase the power to detect associations among the non-filtered
candidates. Common filtering methods include excluding genes with low variance
or low mean (abundance) without referring to any non-genomic data. The rationale
for filtering by variance is that small changes in absolute levels are less likely to be
driving factors for changes in the phenotype. Moreover, such small changes are diffi-
cult to distinguish from measurement noise. For example, in the CKD data, we will
show that genes with low variance tend to have weaker associations with GFR. Figure
4.1 shows the scatterplots of GFR and gene expression for genes with high and low
variance. Similarly, one may argue that genes with very low absolute abundance are
less likely to drive variation in the phenotype, and it is also a challenge to accurately
measure the abundance of such genes with low expression.
The filtering method indicates that mean and variance of the distribution of the
markers may relate to the marker/outcome associations. So mean and variance and
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Figure 4.1: Scatterplots of GFR and gene expression for two specific genes with high
and low variance.
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other familiar statistics like the ordered moments in a distribution will be included in
our marginal properties, so do some statistics specific to the genomic study. Also the
properties could be some function of the observed values of each individual marker,
denoted as M(X1j, · · · , Xnj) or some function of the observed values of one marker
and the other markers, denoted as M(X1j, · · · , Xnj;X). But all of them are using
the empirical distributions of the markers without any information of the outcome.
To be concrete, we only focus on the gene expression data which measures the
information from a gene which is used in the synthesis of a functional gene product.
These products are often proteins or a functional RNA. In genetics, gene expression
is the most fundamental level at which the genotype gives rise to the phenotype. So
it is of essential importance for comparative investigations aiming at discovery of new
genes, functional classification of genes, discovery of relationships between genes and
their products.
4.2.1 Mean level of gene expression data
In microarray experiment, lowly expressed genes should be less important than
highly expressed genes providing a simple and common explanation for the general
relationship observed between gene expression and the different facets of gene evolu-
tion (Gout et al. (2010)). And also reliable measurement is more achievable for highly
expressed genes in a target sample than for those expressed at low levels. Thus, most
of the studies have focussed on high-expressing genes that have high signal intensities
on microarrays. However, this approval may bias the conclusions. Some genes with
low gene expression levels have been detected as important too. For example, low
expression levels of soluble CD1d gene in patients with rheumatoid arthritis had been
shown by Kojo et al. (2003). So the first marginal feature of gene expression data we
are interested in is mean of expression levels for each gene across subjects. Figure 4.2
gives the distribution of mean expression levels of genes in some genomic data after
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Figure 4.2: Distributions of mean expression levels of genes in CKD, Skeletal, Psori-
asis and Cigarette datasets.
the log2 transformation of expression levels. From figure 4.2, we could see that the
distributions of the mean property could be slightly skewed to the right or skewed to
the left in different datasets. Whether genes with high mean expression levels tends
to have more strong relations with the outcome is our question.
4.2.2 Variance of gene expression data
Much of our understanding of biological system is based on interpreting average
behavior, variance has been largely ignored because it has been considered solely in
the context of experimental reproducibility. Now, there is evidence that biological
sources of variance may play an important role in determining cellular and organis-
mal phenotypes, as well as in helping to explain a wide range of biological phenomena
ranging from reduced penetrance to evolutionary fitness (Mar et al. (2011)). If the
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genes have very low variance, a natural interpretation is that those genes are them-
selves highly constrained, and then are less likely to be a driven factor for the changes
in the phenotype. We will check if this is always true.
Here we define our measure of variance of each gene to be:
IQR(p) = pth Quantile− (1− p)th Quantile
which is robust to outliers, and when p = 0.75, this measure is IQR and when p = 0.9,
this measure is IDR.
We may identify the parameter p that has the largest marginal association between
IQR(p) and their external correlations or just choose p = 0.75 as usual. Figure 4.3
is the distribution of IQR of genes in some genomic data. From figure 4.3, we could
see that the distribution of IQR have a very long right tail, most of the IQRs of
genes are around 0-1, with a few genes with very high IQR. Then whether genes with
higher IQR tend to have stronger signals and whether variance is the most important
properties associates with external correlations of all the properties we considered is
our main interest.
4.2.3 Outliers of gene expression data
We should mention that while the term “outlier” has a pejorative meaning in
statistics, it is a very meaningful concept in a biological sense. As noted by Lyons et al.
(2004) and subsequently by Tomlins et al. (2005), the biology of oncogenesis permits
that unique sets of genes may be involved in tumor development across patients.
While statistical outliers refer to measurements that exceed the expected variation
in a set of data, the oncogenetic outliers we seek to find will be putatively related to
cancer processes.
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Figure 4.3: Distributions of IQR of genes in CKD, Skeletal, Psoriasis and Cigarette
datasets.
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| − k)I{(|Xij − X̄i
SD(Xi)
| − k) > 0}, i = 1, · · · ,m,
here we standardized our gene expression data and compare it with some threshold
k (k = 2 in this paper), and to make it robust to outliers, we use IQR/1.349 instead
of SD(X). Since if we have many outliers, the SD(X) tends to be large, this will
make the standardized value to be small, then have small outlier measure, which
kind of cancel each other. Some researcher might want to know if more outliers will
lead to higher correlations between outcome and gene markers. Figure 4.4 shows
the distribution of outlier measures of genes in some genomic data. From figure
4.4, we could see that the distribution of outlier measures is strongly skewed to the
right, with most of the outlier measures around 0-20, while the others have very large
outlier measures. Outlier measures equals 20 means that 20 subjects in this genes
have absolute standardized gene expression value to be 3 with threshold k = 2.
4.2.4 Skewness of gene expression data
Gene expression data tend to have a large proportion of skew and heavy tailed
genes, so we usually take log transformation of the gene expression data to obtain
normality. But there are still some genes are highly skewed after log transformation.





Here we also use IQR/1.349 instead of SD(X) to make it robust to outliers. Variance,
outlier and skewness are three measures of the variation of gene expression data set.
They measure different aspects but have some relationships, like high skewness will
lead to high variance and outlier measure, but high outlier may not lead to high
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Figure 4.4: Distributions of outlier measures of genes in CKD, Skeletal, Psoriasis and
Cigarette datasets.
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Figure 4.5: Distributions of skewness of genes in CKD, Skeletal, Psoriasis and
Cigarette datasets.
skewness. Controlling the marginal association between these three measures to be
not so strong is necessary before include them into regression model.
Figure 4.5 is the distribution of skewness of genes in some genomic data. The
distribution of skewness is almost symmetric around 0 and most of the genes have
skewness around -0.2 to 0.2, which means that most of the genes are symmetric
with only a few genes have very strong positive or negative skewness. Then we
are interested in whether genes with high absolute skewness tend to have stronger
association with the external trait, and within these genes, whether subjects who have
expression levels in the tail of the skewed distribution are in bad or good condition.
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4.2.5 Gene connectivity
Genes and their protein products carry out cellular processes in the context of
functional modules and are related to each other through a complex network of inter-
actions. Correlation of gene expression across a wide variety of experimental pertur-
bations has been shown to cluster genes of similar function. A gene which is highly
correlated with many other genes based on gene expression level is called highly con-
nected nodes in Network and has been found to be relatively more important. For
example, Genes which have high connectivity (i.e. ‘hub’ genes) within a weighted
co-expression network are significantly more likely to be essential for yeast viability
demonstrated by Mar et al. (2011).
In gene co-expression networks, each gene corresponds to a node. The neighbors
of a node i are the nodes that are connected to the node i. Two genes are connected
by an edge with a weight indicating the connection strength. A gene co-expression
network can be represented by an adjacency matrix A = [aij], where aij is the weight
of a connection between two nodes i and j. The connectivity equals the sum of
connection weights substract some threshold.
The choice of the adjacency function determines whether the resulting network
will be weighted (soft thresholding) or unweighted (hard thresholding). A widely
used adjacency function is the signum function which implements ‘hard’ thresholding
involving the threshold parameter τ . Specifically,
aij = I(|cor(xi, xj)| > τ).
Zhang and Horvath (2005) proposed a ‘soft’ power adjacency function:
aij = |cor(xi, xj)|β
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Figure 4.6: Distributions of connectivity of genes in CKD, Skeletal, Psoriasis and
Cigarette datasets.
with the single parameter β. To choose the parameters of an adjacency function:
Only those parameter values that lead to a network satisfying scale-free topology at
least approximately were considered (e.g. signed R2 > 0.80).
Here we choose
aij = (|cor(xi, xj)| − τ)I(|cor(xi, xj)| − τ > 0)







(|cor(xi, xj)| − τ)I(|cor(xi, xj)| − τ > 0),
similar with hard thresholding function with parameter τ = 0.6.
Figure 4.6 shows the distribution of measures of connectivity of genes in some
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genomic data. The distribution is strongly skewed to the right, with most of genes
have connectivity measures equal 0, which means that they are not highly connected
with other genes. Connectivity measure equals 1 means that this gene is highly
correlated with other 10 genes with absolute correlation 0.7 with threshold τ = 0.6.
Then genes with high connectivity are more interesting to us.
4.3 Methodology
4.3.1 Introduction
The project presented in this chapter contributed three novel methodological
ideas. The first contribution is a new framework for understanding marginal marker/outcome
associations in large datasets. This framework involves familiar summary statistics
such as the Pearson correlation coefficients, but applies it in a non-standard way to
derived quantities, rather than directly to the observations. The second contribution
addresses the challenge of assessing the uncertainty in statistics that are aggregated
over large data sets within complex and poorly understand dependencies. We show
that commonly used randomization approaches, while intuitive, can give misleading
results, and we provide a simulation based alternative approach that appears to per-
form well in a variety of situations. The third contribution addresses the issue of
marker/outcome relationships that are strongly non-monotonic. We propose a de-
composition of such relationships into monotonic and “u-shaped” components. This
decomposition allows us to assess the prevalence of these two types of dependency in
large datasets.
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4.3.2 Statistical property of the property/marker/outcome associations
If we use Pearson correlation to represent the marker/outcome association, then
the sample association between gene j and the outcome is
Âj = Ĉor(Xj, Y ) =
n∑
i=1
(yi − ȳ)(Xij − X̄j)
σ̂y ˆσXj
, j = 1, · · · ,m,
where m is the number of genes and n is the number of subjects. The marginal
property of the distribution of gene j isMj. Then we are interested in the relationship
between the sample marker/outcome association Â and marginal property M(X).
The most obvious way is to look at the Pearson correlation between marker/outcome
association and marginal property, which is
θ = Cor(Â,M(X)),
then the estimated correlation is
θ̂ = Ĉor(Â,M(X)).
Since the markers Xj are highly correlated with each other and they all associate
with the same outcome Y, then the marker/outcome associations Aj are highly de-
pendent with each other. If we look at the correlation between marker/outcome asso-
ciations and marginal properties, there might be some “build-in effect” that E(θ̂) ̸= θ
and the stability of the θ̂ is of concern.



















































































Then we know that there is no bias of θ̂ when X and Y are independent. Further
to check the variability of θ̂, we will propose both a simulation-based approach and
a data-based approach.
Usually people will do a permutation test (also called a randomization test) to
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obtain the distribution of the test statistic under the null hypothesis by calculating
all possible values of the test statistic under the rearrangement of the labels on the
observed data points. Here the test statistic is the sample correlation θ̂ and the null
hypothesis is that there is no marker/outcome association and therefore no prop-
erty/marker/outcome association, θ = 0. But this will always mislead the result that
the standard error for θ̂ is always much smaller than the real one. So in this chapter,
we will use simulation-based approach to detect the sampling distribution of θ̂ when
θ = 0.
4.3.3 Function decomposition
Since monotone trend is just one type of marker/outcome relationships which
could be represented by Pearson correlation, in our studies, there exists at least one
other type of marker/outcome relationships, which is called “u-shaped” or symmetric
convex relationship. Then both the lower value and the higher value of marker X
will lead to high/low outcome Y, while the middle values of X will not. These types
of non-monotone associations could not be represented by Pearson correlation, re-
searchers proposed other measures like R2 from fitting natural cubic spline models to
the marker/outcome relationships (Lin et al. (2008)) to represent the non-monotonic
associations. Here we focus on detecting the “u-shaped” associations from the lin-
ear/monotone association and assess the prevalence of these two types of associations
by using a decomposition method.
We will decompose Y into a monotone function and a symmetric convex function
of X (plus a residual term). Then,
E(Y |X) = fsc + fm
where fsc is a symmetric convex function which is a combination of many symmetric
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convex basis functions. fm is a monotone function which is also a combination of
many monotone basis functions. In our situations, we will use the general form
sign(X − X̄)|X − X̄|p
as the monotone basis function and
|X − X̄|p
as the symmetric convex basis function. Here we choose p = 0.5, 1, 2, 3 for mono-
tone basis and add anther basis arctan (X − X̄) for monotone function and choose
p = 0.5, 1, 1.5, 2 for non-monotone basis and add another basis log(X − X̄ − 1) for
non-monotone function. Also we need a constraint for the regression model that the
coefficients for monotone basis functions have the same sign and also the coefficients
for the symmetric convex basis functions have the same sign since the linear combina-
tion of monotone functions are not always a monotone function unless the scalars are
all non-negative or non-positive. We use the nnls package in R program which make
the signs of all the coefficients in the model to be non-negative. By changing the sign
of the predictors in the model, we could regress the model in four situations, when
the sign of the coefficients of the monotone function is positive/negative and the sign
of the coefficients of the symmetric convex function is positive/negative. Then choose
the situation of the highest R2.
Partial R2 for each combination of basis functions is used to quantify the preva-
lence of monotone and non-monotone associations.
4.3.4 Quantile regression model and B-spline basis
In genomic studies, it is known that the distribution of the correlations between
gene expression and traits is heavy-tailed due to the exist of genes have strong effects.
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Also the high positive and high negative correlations are more important than the
average correlation, so the conditional mean model can then become an inappropriate
measure just focusing on central tendencies but fail to capture informative trends in
the response distribution. It is quite natural to go beyond location and scale effects
of predictor variables on the response and ask how changes in the predictor variables
affect the underlying shape of the distribution of the response.
Quantile regression, which models conditional quantiles as function of predictors,
specifies changes in the conditional quantile of the dependent variable associated with
a change in the covariates. Since multiple quantiles can be modeled, it is possible
to achieve a more complete understanding of how the marker/outcome correlations
are affected by marginal properties of the markers, including information about shape
change. As in linear regression, the methodology we present is easily adapted to more
complex model specifications, including interaction terms and polynomial or spline
functions of covariates.
The quantile regression model can be expressed as:
QY (τ |X) = α(τ) + β(τ)X,
where τ is the possible quantiles of the outcome we are interested in. We may estimate




ρτ (yi − α− βXi),
where ρτ (u) = u(τ − I(u < 0)). Compared to linear regression that the coefficients




(yi − α− βXi)2.
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Since the goodness of fit R2 for linear model is defined by using 1 substract the sum of
squared residuals of the full model Ŝ over the sum of squared residuals of the model
with no covariate S̃ :
R2 = 1− Ŝ/S̃ = 1− ||Y − Ŷ ||2/||Y − Ȳ ||2.
We may proceed in the same manner for quantile regression, we define R1(τ) as
the goodness of fit for quantile regression with quantile τ which is defined by using
1 substract the weighted sum of absolute residuals of the full model V̂ (τ) over the
weighted sum of absolute residuals of the model with no covariate Ṽ (τ),:
R1(τ) = 1− V̂ (τ)/Ṽ (τ),
where V̂ (τ) =
∑n
i=1 ρτ (yi − α̂ − β̂Xi), Ṽ (τ) =
∑n
i=1 ρτ (yi − a), constant a is the τ ’s





where R11(τ) is the goodness of fit R
1 of a quantile regression model without including
the variables you are interested in for a particular quantile τ , andR12(τ) is the goodness
of fit R1 of a full quantile regression model for a particular quantile τ .
Like R2, it is immediately apparent that V̂ (τ) ≤ Ṽ (τ), and this R1(τ) lies be-
tween 0 and 1. Unlike R2, which measures the relative success of two models for the
conditional mean function in terms of residual variance. R1(τ) measures the relative
success of the corresponding quantile regression models at a specific quantile in terms
of an appropriately weighted sum of absolute residuals. Thus R1(τ) constitutes a
local measure of goodness of fit for a particular quantile rather than a global measure




To estimate the sampling distribution of θ̂, the sample correlation between marker/outcome
association A and marginal properties M under the null hypothesis that θ = 0, we
could provide a simulation-based approach to see if there is any bias of θ̂ to θ and
the variability of θ̂. The following are the simulation steps.
1. Generate outcome Yi, i = 1, · · · , n from standard normal distribution and Fisher
transformation of marker/outcome association Zj, j = 1, · · · , p from a normal
















n− 3 + 1
.
2. Generate covariate Xj which has Pearson correlation Aj with Y by using
Xj = Aj × Y +
√
1− A2jϵj, (4.1)
where ϵ has mean 0 and variance 1. To make covariates X to be correlated with
each other, the covariance matrix of ϵ, Σϵ has the form that it has k diagonal
blocks with equal size p/k and it is compound symmetric structure in each block
with parameter a. Then
ϵij = a× Ui +
√
1− a2ηij, i = 1, · · · , k, j = 1, · · · , p/k,
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where Ui ∼ N(0, 1), ηij ∼ N(0, I). Then cor(ϵij, ϵil) = a2, cor(ϵij, ϵql) =
0, i ̸= q. Then the correlation of each Xi, Xj pair would be ρij = AiAj +√
1− A2i
√
1− A2ja2 if i, j in the diagonal blocks and ρij = AiAj otherwise. if
a = 0, ϵ ∼ N(0, I).
3. Generate marginal mean propertyM1 ∼ N(µ1, σ1), SD propertyM2 ∼ N(µ2, σ2),
and skew propertyM3 ∼ N(µ3, σ3). To make the covariate X to have these prop-
erties, first we need ηij which is used to construct ϵij to be skewed and standard-
ized, let ηij follows Gamma distribution with shape s and scale 1, then the skew-
ness of ηij equals 2/
√







which should equals M3j . Then s = 4(1 − A2j)3(1 − a2)3/(M3j )2. After Xj is
constructed using formula
Xj = Aj × Y +
√
1− A2jϵj
ϵij = a× Ui +
√
1− a2ηij, i = 1, · · · , k, j = 1, · · · , p/k,
scale Xj by M
2
j and linear transform Xj by M
1
j , then covariate Xj will have
desired marginal properties M1,M2,M3.
4. Sample marker/outcome association Âj = Ĉor(Y,Xj) is calculated and M̂j
which is the sample marginal property of Xj is calculated too. Then the sam-
ple correlation θ̂ between Âj and M̂j is calculated. We are interested in the
change of mean and standard error of θ̂ with different standard deviation of
fisher transformation of marker/outcome correlation σz. Also other aspects
that could affect the amount of change of standard error of θ̂ caused by σz, like
number of subjects n, number of variables p, correlations within covariate X
and parameters of marginal properties.
5. Also we would like to compare this simulation result with permutation re-
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sult. There are only two steps different with simulation. One is that the
marker/outcome associations Aj and the marginal properties Mj has some cor-




where M is the marginal property, λ follows a standard normal distribution and
is independent with M, r0 is the correlation between Z and M. The other step
is that when X and Y are generated, permute Y with replacement while make
X fixed, which give the assumption that population property/marker/outcome
correlation θ = 0. Then the sample correlation θ̂ between sample marker/outcome
association Âj and marginal mean M̂j is calculated, and also we are interested
in change of mean and standard error of θ̂ with different standard deviation of
fisher transformation of marker/outcome correlation σz.
4.4.2 Simulation results for SD(θ̂)
Overall the expectation of θ̂ always equals to θ when θ = 0 which is consistent
with the theoretical derivation of E(θ̂). The standard error of θ̂ will increase
when the standard deviation of marker/outcome association, σz increase. Fur-
thermore, the amount of increase of standard error of θ̂ caused by σz is affected
by some other attributes.
First we look at the standard deviation of mean property, σ1 when holding
other attributes fixed. From figure 4.7, we know that the amount of increase
of standard error of θ̂ between Âj and mean property M
1 caused by σz will
decrease with increasing σ1, and the amount of increase of standard error of
θ̂ between Âj and skew property M
3 caused by σz will become constant with
increasing σ1, while the standard error of θ̂ between Âj and SD property M
2
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will not change with different σz and σ1.
Secondly, we look at the mean of SD property, µ2 when holding the other
attributes fixed. From figure 4.8, we know that the amount of increase of
standard error of θ̂ between Âj and mean propertyM
1 caused by σz will increase
with increasing µ2, and the amount of increase of standard error of θ̂ between
Âj and skew property M
3 caused by σz will become constant with increasing µ2,
while the standard error of θ̂ between Âj and SD property M
2 will not change
with different σz and µ2.
Actually we could see that the SD of mean property and the mean of SD prop-
erty is just the between variance and within variance of covariate X. So we
combine these two attributes to one attribute called “within/between variance
V ”, defined as the mean of the variance of Xj over the variance of mean of Xj.
From figure 4.9, we know that the amount of increase of standard error of θ̂
between Âj and mean property M
1 caused by σz will increase with increasing
within/between variance, and the amount of increase of standard error of θ̂
between Âj and skew property M
3 caused by σz will become constant with in-
creasing within/between variance, while the standard error of θ̂ between Âj and
SD property M2 will not change with different σz and within/between variance.
Next, we look at the correlation within covariate X, the average ρ2ij, where ρij
represent the Pearson correlation between Xi and Xj, will be determined by the
number of diagonal blocks k and the parameter a. From figure 4.10, we could
see that the value of the correlation between Xi, Xj pairs will not change the
amount of increase of standard error of θ̂ caused by σz.
Then, we look at how number of subjects n and number of variables p influence
the amount of increase of standard deviation of θ̂. From figure 4.11, we know
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Figure 4.7: Plots of standard error of θ̂ and standard deviation of fisher transfor-
mation of marker/outcome association with different level of standard
deviation of mean property. In the left plot, θ̂ is the correlation between
marker/outcome association and mean property ; In the middle plot, θ̂ is
the correlation between marker/outcome association and SD property; in
the right plot, θ̂ is the correlation between marker/outcome association
and skewness property. n=100, p=1000, a=0, µ1 = 0, µ2 = 1, σ2 = 0,
µ3 = 0, σ3 = 0.
106
Figure 4.8: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different level of mean of SD
property.In the left plot, θ̂ is the correlation between marker/outcome
association and mean property; in the middle plot, θ̂ is the correlation
between marker/outcome association and SD property; in the right plot,
θ̂ is the correlation between marker/outcome association and skewness
property. n=100, p=1000, a=0, µ1 = 0, σ1 = 0.5, σ2 = 0, µ3 = 0, σ3 = 0.
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Figure 4.9: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different level of within/between
variance. In the left plot, θ̂ is the correlation between marker/outcome
association and mean property; in the middle plot θ̂ is the correlation
between marker/outcome association and SD property; in the right plot,
θ̂ is the correlation between marker/outcome association and skewness
property. n=100, p=1000, a=0, µ1 = 0, σ2 = 0, µ3 = 0, σ3 = 0.
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Figure 4.10: Plots of standard error of θ̂ and standard deviation of fisher transfor-
mation of marker/outcome association with different level of within cor-
relation of covariate X. θ̂ is the correlation between marker/outcome
association and mean property, number of diagonal blocks k=1 in the
left plot and k=2 in the right plot. n=100, p=1000, µ1 = 0, σ1 = 0.5,
µ2 = 1, σ2 = 0, µ3 = 0, σ3 = 0.
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that the amount of increase of standard error of θ̂ between Âj and mean property
M1 caused by σz will decrease with increasing number of subjects n, so does
skew property M3, while the standard error of θ̂ between Âj and SD property
M2 will not change with different σz and number of subjects n.
From figure 4.11, we know that the sampling errors of the correlation between
marker/outcome association and marginal property follows a normal distribu-
tion with mean 0 and standard deviations 1/
√
p, so the standard deviation of
θ̂ will always increase with decreasing number of variables p. So the standard
error of θ̂ between Âj and SD property M
2 is just due to the sampling error
while the the standard error of θ̂ between Âj and mean property M
1 is not just
caused by the sampling error, it is also caused by the standard deviation of
marker/outcome association σz. When σz is small, the standard deviation of θ̂
is mainly due to the sampling error. Eith increasing σz, the standard deviation
of θ̂ will increase, and the amount of increase will increase when p increase. In
the end, when σz is extremely large, the standard deviation of (̂θ) will converge
no matter the number of p is. And the property of the standard deviation of
θ̂ between Âj and Skew property M
3 is somewhere between SD property and
Mean property.
Overall in the simulation study, the standard deviation of θ̂ between marker/outcome
association A and Mean property M1 will increase when the standard deviation
of marker/outcome association, σz increase. The amount of increase will be
enhanced when the number of subjects n decrease, the number of variables p
increase and the within/between variance V of covariate X increase. The stan-
dard deviation of θ̂ between marker/outcome association Âj and Skew property
M3 will increase when the standard deviation of marker/outcome association, σz
increase. But the amount of increase will be not affected by the within/between
variance V of covariate X, the other patten is the same with Mean property. At
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Figure 4.11: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different number of subjects n.
In the left plot, θ̂ is the correlation between marker/outcome associa-
tion and mean property; in the middle plot, θ̂ is the correlation between
marker/outcome association and SD property; in the right plot, θ̂ is the
correlation between marker/outcome association and skewness property.
p=1000, a=0, µ1 = 0, σ1 = 0.5, µ2 = 1, σ2 = 0, µ3 = 0, σ3 = 0.
111
Figure 4.12: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different number of variables
p. In the left plot, θ̂ is the correlation between marker/outcome associa-
tion and mean property; in the middle plot, θ̂ is the correlation between
marker/outcome association and SD property; in the right plot, θ̂ is the
correlation between marker/outcome association and skewness property.
n=100, a=0, µ1 = 0, σ1 = 0.5, µ2 = 1, σ2 = 0, µ3 = 0, σ3 = 0.
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last, the standard deviation of θ̂ between marker/outcome association Âj and
SD property M2 will be not affected by σz, it is only due to the sampling error
of the correlation of two vectors.
4.4.3 Simulation results for SD(θ̂) under permutation analysis
In permutation analysis of the simulated data set, we permute Y while keeping
covariate X fixed, then the marker/outcome association has mean 0 and stan-
dard deviation σz = 0 and also the population correlation between marker/outcome
association and marginal property θ equals 0. This is just the case in simulation
study when σz = 0, known that the standard error of θ̂ will increase when σz
increase, then the standard error of θ̂ calculated by permutation is smaller than
the case when σz is not zero, which is always true in real case. Then we will
be more likely to reject the null hypothesis that θ = 0 and conclude that the
marginal property has some association with the marker/outcome association.
But we should realize that in real data set, there is always some sample corre-
lation θ̂ could be detected between marker/outcome association and marginal
property, which is not 0, or we don’t need to do the permutation analysis to con-
struct the standard error of θ̂ under null hypothesis and test for significance. So
we need to add one step before simulation step 1 that the marker/outcome asso-
ciation Aj should be correlated with the marginal property Mj at first. Though
by permutation analysis, the expected correlation E(θ̂) between Aj and Mj is
forced to be 0, there is always more standard errors of θ̂ when the correlation
between Âj and M̂j is large in real case.
From figure 4.13, we see that the the amount of increase of the standard error
of θ̂ between marker/outcome association Âj and marginal property M̂ caused
by σz will increase when the absolute value of the real correlation between
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marker/outcome association Âj and marginal property M̂ is increased.
4.4.4 Simulation results of SD(θ̂) using the property of the CKD data
As shown above, the standard deviation of the estimated property/marker/outcome
associations θ̂ is affected by many factors of the data generating models, like the stan-
dard deviation of the marker/outcome associations σz, the within/between variance
of covariate V , the correlation structure of the gene pairs and so on. So it is hard
to decide whether the standard deviation of the estimated property/marker/outcome
associations θ̂ is underestimated or overestimated under the permutation technique
that researchers usually use to detect the significance of the property/marker/outcome
associations.
Here we tried to match the factors of the simulated data to the real CKD data
and then compare the standard deviation of θ̂ under permutation analysis with the
true simulation analysis. The procedure is similar with the simulation steps in 4.4.1.
We use n = 195, p = 12000, the marginal mean property, SD property and skew
property is calculated from the CKD data. For a grid of τ from -1 to 1, assume that
the marker/outcome associations Aj is correlated with marginal mean property with
correlation τ and follows a normal distribution with mean 0 and standard deviation
0.2. The covariance matrix Σx has 5 diagonal blocks with equal sample size 2400, and
in each block there is a compound symmetric structure with correlation parameter
a = 0.7 to make the the average squared correlation of gene pairs Xi, Xj equals 0.04
which is consistent with the CKD data. Then using the approaches in simulation
steps 3, we make the covariate Xj has the same marginal properties.
Now the simulated data (X,Y ) is generated, we could calculate the sample marker/outcome
association Âj, the sample marginal properties M̂ , and then the estimated prop-
erty/marker/outcome association θ̂ is calculated. For permutation analysis, we need
to permute our outcome Y while holding covaraites X fixed, then calculate the esti-
114
Figure 4.13: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different levels of the absolute
value of the real θ̂ in permutation analysis. In the left plot, θ̂ is the
correlation between marker/outcome association and mean property; in
the middle plot, θ̂ is the correlation between marker/outcome associ-
ation and SD property; in the right plot, θ̂ is the correlation between
marker/outcome association and skewness property. n=100, p=1000,
a=0, µ1 = 0, σ1 = 0.5, µ2 = 1, σ2 = 0, µ3 = 0, σ3 = 0.
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mated property/marker/outcome association θ̂. Figure 4.14 compares the standard
deviation of θ̂ for simulation and permutation analysis, and shows that the permuta-
tion technique will overestimate the standard deviation of θ̂ in CKD data set, then
lead to unsignificant result while it is more likely to be significant in truth.
In the approaches above, we try to match the average squared correlation of gene
pairs Xi, Xj in simulated data to the real data, and assume that it is good measure
of the dependency between covariates X. But it may not capture the most property
of the dependence structure of covariates X. Then we illustrate another method to
capture the dependence structure of covariates X. We calculate the residuals of Xj|Y
by regressing Y on each gene marker Xj, then calculate the covariance matrix of
the residuals, Σr. Let ϵj in equation 4.1 has the same covariance structure Σr. The
remaining procedures are the same with the procedures above. Figure 4.15 compares
the standard deviation of θ̂ for simulation and permutation analysis, and shows that
the permutation technique will still overestimate the standard deviation of θ̂ in CKD
data set. The difference between these two procedures is that the magnitude of
overestimate for permutation technique is different and we believe that the second
procedure is more close to the real case.
4.5 CKD data Example
In CKD dataset, 12023 genes and 195 subjects are involved and the glomerular
filtration rate (GFR) is used as external trait Y. Glomerular filtration rate (GFR)
is a test used to check how well the kidneys are working. Specifically, it estimates
how much blood passes through the tiny filters in the kidneys, called glomeruli, each
minute. Lower GFR means kidney is not working very well represents patients with
severer kidney disease. So it is reasonable that GFR is left skewed since there are few
people with very bad GFR and the other people with normal GFR which is consistent
with the distribution of GFR in figure 4.16.
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Figure 4.14: Plots of standard error of θ̂ and standard deviation of fisher transforma-
tion of marker/outcome association with different levels of real θ in both
simulation and permutation analysis for three marginal properties. All
the factors of the simulated data are matched to the CKD data and the
average squared correlation of gene pairs Xi, Xj is used to represent the
covariance structure of X.
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Figure 4.15: Plots of standard error of θ̂ and standard deviation of fisher transfor-
mation of marker/outcome association with different levels of real θ in
both simulation and permutation analysis for three marginal properties.
All the factors of the simulated data are matched to the CKD data and
the covariance matrix of the residuals of Xj|Y is used to represent the
covariance structure of X. The red line is for permutation analysis, the
blue line is for simulation analysis.
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Figure 4.16: Histogram of distribution of GFR in CKD data.
The five marginal features of gene expression across subjects in CKD data are
calculated based on the definition on section 4.2. Here we choose p = 0.75 for the
measure of variance, which is IQR. After each marginal feature is calculated, we
construct cubic B-spine with (k=3, df=3) for each measurement and then use them
as the covariates and the sample pearson correlations r̂ between gene expression and
GFR as the outcome in the quantile regression model with quantiles vary from 0.05
to 0.95.
4.5.1 Relations between external correlations and each feature
First, marginal quantile regression of r̂ and B-spine of each marginal feature is
made and figures 4.17-4.21 are the plots of predicted quantiles vary from 0.05 to 0.95
and each marginal feature and the goodness of fit R1 is calculated for each regression.
Figure 4.17 shows that skewness has a negative relationship with the quantiles
of correlations between gene expression and GFR. The predicted quantiles are par-
allel, then we could use the center of the predicted quantiles, the median quantile
to represent the whole pattern. The average external correlations for genes decrease
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linearly when the skewness of the genes increase and the external correlations are
usually negative when their corresponding skewness are positive and the external
correlations are usually positive when their corresponding skewness are negative. If a
gene with expression value skew to the right, it has positive skewness and then leads
to negative correlation between GFR and gene expression. Since lower GFR is bad,
which means higher gene expression level is bad for this particular gene, then people
have higher expression level on this gene or have expression level in the right tail are
in poor situation. On the other hand, if a gene with expression value skew to the
left, it has negative skewness and then leads to positive correlation between GFR and
gene expression. Then people have lower expression level on this gene or in the left
tail are in poor situation.
Figure 4.22 give examples of genes in CKD data that are highly skewed and
have high correlation between gene expression and GFR. The left scatterplot is for
gene which is positively skewed and then have high negative external correlation. The
subjects on the right tail have lower GFR, then in bad situation. The right scatterplot
is for gene which is negatively skewed and then have high positive external correlation.
The subjects on the left tail have lower GFR, then in bad situation. In summary, for
genes with non-symmetric distribution across subjects, people have gene expression
value in the tail of the distribution are in poor situation. Does the conclusion still
true that for genes with symmetric distribution, people have gene expression value
in the tail are also in poor situation? We will discuss it later. Also in this CKD
dataset, genes are more likely to be right skewed, which is the same with what people
expect that there may be more right skewed genes since there is low boundary for
gene expression level that gene expression values are always greater than 0. If we
choose 0.4 as the threshold, then there are 841 genes have skewness greater than 0.4,
while only 218 genes have skewness smaller than −0.4.
Then we look at figure 4.18, the plot of predicted quantiles of external correlations
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and IQR, there is a fan pattern of the predicted quantiles, that the tail distribution
of external correlations is more spread with the larger IQR. Then genes with larger
IQR tend to be more correlated with GFR, either negative or positive but the tend
is weaken when gene’s IQR are relatively large. If one gene is positively correlated
with GFR, then people have low expression level on this gene tends to have low GFR,
then in poor situation, on the other hand, if one gene is negatively correlated with
GFR, then people have high expression level on this gene are in poor situation. But
if one gene does not have much linear relationship with GFR (low correlation with
GFR), it could still be interesting, since there could be a symmetric concave/convex
relationship between this gene and GFR, then people have high expression level and
low expression level are both in poor or good situation.
Figure 4.23 gives examples of genes in CKD data that are symmetric distributed
across subjects and have strong linear relationship with GFR and also examples of
genes in CKD data that have symmetric concave/convex relationship with GFR. Then
the question is, for genes with symmetric distribution, people have gene expression
level in the tail are more likely to be both in poor situation or just one tail is bad,
the other is good. In other words, are genes more likely to have strong linear trend
with GFR or strong symmetric convex/concave relation with GFR?
From figure 4.19, the overall pattern of mean and external correlation is that
for genes with lower expression levels, genes are more likely to be highly negatively
correlated with the GFR than highly positively correlated, but when expression level
goes up, the pattern disappears, there are equally highly positively correlated genes
and highly negatively correlated genes and overall, genes with high mean expression
level are more likely to be highly correlated with GFR. Then not only the genes with
high mean expression level are of interest, genes with low mean expression level could
still be interesting due to our finding. The overall pattern of connectivity and external
correlation from figure 4.20 is that genes with higher connectivity measure are more
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Figure 4.17: Plot of predicted quantiles from 0.05 to 0.95 of external correlations and
skewness of gene expression in CKD data.
likely to be highly correlated with GFR and the number of highly positively correlated
genes is much higher than the number of highly negatively correlated genes.
At last, we look at the overall pattern of outlier features and external correlations
from figure 4.21. There are slightly decreasing trend of external correlations with the
increasing of outlier measure, which means for gene with more outliers, it is more
likely that the gene is highly negatively correlated with GFR. Since there are more
positively skewed genes than negatively skewed, outliers are more likely to be on the
right side of the gene, then subjects who are the outliers of one gene are more likely
to have high gene expression levels and then in poor situation. The conclusion for
outlier measure is quite similar with skewness, and the pearson correlation between
outlier and skewness are 0.63 in CKD data. Here comes our next question, will the
effect of outlier on the external correlations mainly due to the effect of skewness or
in the opposite way that the effect of outlier is dominant? Of all the five marginal
features, which is the most dominant feature?
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Figure 4.18: Plot of predicted quantiles from 0.05 to 0.95 of external correlations and
IQR of gene expression in CKD data























Figure 4.19: Plot of predicted quantiles from 0.05 to 0.95 of external correlations and
mean of gene expression in CKD data
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Figure 4.20: Plot of predicted quantiles from 0.05 to 0.95 of external correlations and
connectivity of gene expression in CKD data























Figure 4.21: Plot of predicted quantiles from 0.05 to 0.95 of external correlations and
outlier of gene expression in CKD data
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Figure 4.22: Examples of genes in CKD data that are highly skewed and have strong
linear relationship with GFR.
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Figure 4.23: Left plot is an example of genes in CKD data that are symmetric and
have strong linear relationship with GFR. Right plot is an example of
genes in CKD data that are symmetric and have symmetric convex re-
lationship with GFR.
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4.5.2 Relations between marginal features
Though the five marginal features of genes are mathematically uncorrelated. For
example, genes with high mean could have low variance, genes with high variance
could be symmetric or skewed to the left or right. But in real case, there always be
some correlations between these five marginal features. Table 4.1 shows the pearson
correlation between any two of the marginal features, and the tolerance score which
gives the strength of multicollinearity. Tolerance is calculated by using 1−R2j , where
R2j is the coefficient of determination of a regression of explanator j on all the other
explanators. A tolerance of less than 0.2 or 0.1 indicates a multicollinearity problem.
Except the CKD data set, we use other three data sets, the skeletal muscle data,
psoriasis data and cigarette data. The skeletal muscle data is used to analysis of vas-
tus lateralis muscle biopsies from insulin-sensitive subjects, insulin-resistant subjects
and diabetic patients following insulin treatment with 12626 genes and 110 samples
where 60 samples are measured before Insulin treatment and 50 samples after Insulin
treatment. Then this data could be used as two datasets before and after Insulin treat-
ment. Psoriasis data is used to analyze lesional and non-lsional skins from patients
with psoriasis with 54675 genes and 82 samples. We just use 61 samples excluding 21
control samples. Cigarette data analyze the cigarette smoke effect on the oral mucosa
with 54675 genes and 79 samples divided into 39 smokers and 40 non-smokers. Then
we could still use this data as two datasets with smokers and non-smokers.
From table 4.1, we see that in CKD dataset, there is some positive relationship
between mean and variance, and outlier and skewness has the highest correlation 0.63
since higher skewness will lead to higher outlier measure, and also the outliers are
more likely to on the right side, not on both sides. We could still see that variance and
connectivity have some relationship because if one gene has very low variance, which
means that every subject has very similar gene expression value then it should have
no correlations with other genes. Since there is no high multicollinearity between our
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Table 4.1: Relations among marginal features of gene expression data sets
CKD IQR Skewness Outlier Connectivity Tolerance
n=195 0.28 -0.16 -0.2 0.26 0.84 Mean
-0.09 0.09 0.34 0.79 IQR
0.63 0.06 0.58 Skewness
0.01 0.56 Outlier
0.84 Connectivity
Skeletal muscle IQR Skewness Outlier Connectivity Tolerance
before treatment -0.04 0.17 0.25 -0.26 0.85 Mean
n=60 0.07 -0.30 -0.15 0.85 IQR
-0.72 -0.2 0.35 Skewness
0.57 0.24 Outlier
0.52 Connectivity
Skeletal muscle IQR Skewness Outlier Connectivity Tolerance
after treatment -0.21 -0.19 0.21 0.24 0.84 Mean
n=50 -0.08 -0.12 0.12 0.85 IQR
0.16 0.01 0.90 Skewness
0.69 0.46 Outlier
0.46 Connectivity
Psoriasis IQR Skewness Outlier Connectivity Tolerance
n=61 0.49 -0.06 -0.25 0.34 0.81 Mean
-0.05 -0.24 0.32 0.85 IQR
0.63 -0.08 0.70 Skewness
-0.12 0.79 Outlier
0.73 Connectivity
Cigarette smokers IQR Skewness Outlier Connectivity Tolerance
n=40 0.25 -0.02 -0.04 0.08 0.99 Mean
-0.01 -0.13 0.53 0.69 IQR
0.64 -0.03 0.72 Skewness
-0.10 0.69 Outlier
0.71 Connectivity
Cigarette non-smokers IQR Skewness Outlier Connectivity Tolerance
n=39 0.25 -0.02 -0.05 0.10 0.99 Mean
-0.01 -0.14 0.44 0.78 IQR




5 marginal properties, we could include all of them in the multiple regression model.
The finding is similar in psoriasis data and cigarette data. There is some positive
correlation between mean and variance, and outlier and skewness has the highest
positive correlation. In cigarette data, there is also some positive relationship between
variance and connectivity, which means genes have higher variance are more likely to
be highly connected with other genes.
While in skeletal muscle data, the relationships between marginal features might
be different. First, mean and variance has some negative relationship, this may cause
some problem when you filter the genes with low mean and low variance, then some
genes with high mean expression level are also removed, which will lead to losing
some important information. Also the high positive correlation between outlier and
connectivity which is 0.69 for skeletal muscle data after treatment and 0.57 before
treatment means that genes with more outliers tend to be more correlated with other
genes. There is high negative correlation between skewness and outliers which is -0.72
for skeletal muscle data before treatment which is just opposite with the relationship
we found in CKD dataset, which means genes are more likely to have outliers on the
left side or genes are more likely to skewed to the left, then there are some genes have
very low expression values.
When we do simple regression, we must be cautious in looking at the effect of
one predictor to the outcome. It is commonly accepted that effect of factor A to the
outcome is weaken if there is an alternative factor that is related to factor A as well
as the outcome. For example, in CKD dataset, there may be trends between external
correlations and both variability and skewness. But variability and skewness are also
correlated. Then it is not acceptable if we just do marginal simple regression of
external correlations on variability or skewness and conclude that genes with certain
level of variability or skewness tend to show high external correlations. Statistical
control of “confounding” is to include it as a covariate in a quantitative model. So if
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all the five marginal features are correlated and each of them has relationship with
the outcome, we should include all of the five marginal properties in one multiple
regression model and then we could look at the partial R2 which quantify how much
unique information about outcome in one covariate is not captured by the other
covariates, then predictor with the largest partial R2 is considered to be the most
important predictor. Another way is controlling for one factor, then look at the
relationship between the other factor and outcome. For example, we could control
for the effect of skewness by dividing the genes into several groups with different
value of absolute skewness, then see if the relationship between variance and external
correlations still exists.
4.5.3 The most dominant feature
First, we include all the marginal features in one quantile regression model, the
partial R1 is calculated by using the formula
partialR1 = (R1,total −R⋆1)/(1−R⋆1)
where R1,total is the total R1 when all the features are included in the model and
R⋆1 is the R1 when one specific feature is not included in the model while others
are. Then it quantifies how unique information of one specific feature to the external
correlations. Figure 4.24 shows the marginal R1 and partialR1 for our five features,
we could see that the average partialR1 across all the quantiles for mean is 0.007, IQR
is 0.008, Outlier is 0.015, Skewness is 0.05 and Connectivity is 0.012. The importance
of skewness is 3-4 times more than the other marginal features on average of the
multiple quantile regression. So the most important predictor in quantile regression
is skewness and the second important predictor is outlier, the third is connectivity.
Second, we do the marginal regression of one feature while controlling the value of
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Figure 4.24: Left plot is R1 for quantile regression of external correlations and each
feature; Right plot is partial R1 for multiple quantile regression, com-
paring full model and full model without one feature at each time.
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another feature. It is well known that if feature A has strong relation with outcome
and also feature A and feature B are highly correlated with each other, then feature B
will also have some relation with the outcome, though in fact, feature B is independent
with the outcome. Then if we control for the value of feature B, though the domain
and density of feature A will change, the effect of feature A to the outcome will not
change. On the other hand, if we control for the value of feature A, the effect of
feature B to the outcome will disappear due to the true relationship between feature
B and outcome is independent. From the results of multiple quantile regression, we
know that skewness is the most dominant feature. To check that, let’s control for the
other features to see if the relationship between skewness and external correlations
changes.
We first control for the effect of IQR to see how the relationship between skewness
and external correlations changes due to different levels of IQR. We order genes with
their IQR values and divide genes into three groups based on their IQR values and
then the low IQR group contain the lowest 1/3 genes with IQR smaller than 0.25.
Middle IQR group contains the middle 1/3 genes with IQR between 0.25 and 0.38 and
high IQR group contains the top 1/3 genes with IQR greater than 0.38. Within each
IQR group, we will do the marginal quantile regression on skewness feature. Figure
4.25 shows that the relationship between skewness and external correlations does not
change when controlling for the effect of IQR. Then we also control for the effect of
mean, outlier and connectivity with the same procedure, from figure 4.26-4.28, we
know that the relationship between skewness and external correlations remains the
same. These results are consistent with what we find using partialR1.
4.5.4 Function deconvolution result
The second topic for this section is for symmetric genes, are they more likely to be
linearly correlated with GFR or have a symmetric concave/convex relationship with
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Figure 4.25: Plot of predicted quantiles of external correlations and skewness of gene
expression for three gene sets with different level of IQR.
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Figure 4.26: Plot of predicted quantiles of external correlations and skewness of gene
expression for three gene sets with different level of mean.
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Figure 4.27: Plot of predicted quantiles of external correlations and skewness of gene
expression for three gene sets with different level of outlier.
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Figure 4.28: Plot of predicted quantiles of external correlations and skewness of gene
expression for three gene sets with different level of connectivity.
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GFR? Here we deconvolve the function of E(Y |X) into a monotone function and a
symmetric convex function and a residual term. Then,
E(Y |X) = fsc + fm + r
In our situation, outcome Y is GFR and X is gene expression value for each
gene and we use X − X̄, (X − X̄)3, sign(X − X̄)(X − X̄)2, sign(X − X̄)
√
X − X̄,
arctan(X − X̄) as the basis monotone functions and
√
|X − X̄|, |X − X̄|, |X −
X̄|1.5, |X − X̄|2, log (X − X̄ − 1) as the basis symmetric convex function. Then our
regression model becomes:
Y = β0 + β1(X − X̄) + β2(X − X̄)3 + β3 arctan(X − X̄)
+β4sign(X − X̄)(X − X̄)2 + β5sign(X − X̄)
√
X − X̄ + β6|X − X̄|+ β7|X − X̄|1.5
+β8|X − X̄|2 + β9
√
|X − X̄|+ β10 logX − X̄ − 1 + ϵ
where E(ϵ|X) = 0, V ar(ϵ|X) = σ2. And we need sign(β1) = sign(β2) = sign(β3) =
sign(β4) = sign(β5) and sign(β6) = sign(β7) = sign(β8) = sign(β9) = sign(β10).
We use the nnls package in R program and regress the model in four situations, when
the sign of the coefficients of the monotone function is positive/negative and the sign
of the coefficients of the symmetric convex function is positive/negative. Then choose
the situation of the highest R2 for each symmetric gene (in the low skewness group).
Then partial R2 for monotone function and partial R2 for symmetric convex function
are calculated for each gene and they are plotted in figure 4.29. Using threshold 0.1,
then about 4% of the symmetric genes are demonstrated to be linearly correlated
with GFR, while 0.2% genes show strong symmetric convex/concave relation with
GFR.
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Figure 4.29: Plot of partial R2 of linear term and partial R2 of quadratic term.
4.6 Challenge and conclusion
We focus on a new question that relate the effect sizes (marker/outcome associa-
tions) to the properties of marginal distribution of the markers. This new framework
for understanding marginal marker/outcome associations in large datasets involves
familiar summary statistics such as the Pearson correlation coefficients, but applies it
in a non-standard way to derived quantities, rather than directly to the observations.
We use the quantile regression with spline basis technique to model the relationships
between the marker/outcome associations and the five marginal properties with a L1
goodness of fit R1 in real data analysis. We figure out that the skewness property
has the strongest association with the marker/outcome association and dominate the
other marginal properties.
Then we addresses the challenge of assessing the uncertainty in statistics that
are aggregated over large data sets within complex and poorly understand depen-
dencies. We show that commonly used randomization approaches, while intuitive,
can give misleading results, and we provide a simulation based alternative approach
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that appears to perform well in a variety of situations. Also applied this approaches
to the real data, we compare the standard deviation of the statistic of simulation
based approach to the randomization approach and find out that the randomization
approach overestimates the standard deviation of the statistic and tends to make the
property/marker/outcome association unsignificant.
Then we addresses the issue of marker/outcome relationships that are strongly
non-monotonic. We propose a decomposition of such relationships into monotonic
and “u-shaped” components. We find out that the monotone marker/outcome asso-
ciations are more likely to exist in CKD data than the “u-shaped” associations, then
use Pearson correlation coefficients to represent the marker/outcome associations is
reasonable.
There is also a challenge for the regression model, that the external correlations
between GFR and gene expression data are themselves correlated since we calcu-
lated the correlations with the same outcome GFR, then the dependent variable in
regression model is correlated or the error term in the regression model is correlated
which violate the assumption for quantile regression that the quantiles of the error
terms given covariates are independent. Therefore the estimated coefficients of the




In this thesis, we consider several challenging issues that arise when analyzing
genomic data. Difficulties that arise in this area commonly result from the effects
of covariate measurement error, complicated dependence structure, and data sets
with high dimension and small sample size. Chapter 2 focuses on the statistical
assessment of predictive performance due to covariate measurement error. Chapter
3 focuses on proposing a new method to measure the overlap effect sizes in two
subpopulations in genomic study. Chapter 4 focuses on a new question that relate the
effect sizes (marker/outcome associations) to the properties of marginal distribution
of the markers.
In chapter 2, we first demonstrate that the predictive performance is negatively af-
fected by the increase of magnitude of measurement error. The effect is also influenced
by other factors of data generating model related to the true regression coefficient β,
the covariance matrix of true covariates X, Σx, and the covariance matrix of the mea-
surement error, Ση. Then we identify these factors from the theoretical derivation
of predictive accuracy AUC, we find that there are four factors might influence the
decline of predictive accuracy and similar findings is shown for the linear case. Also in
the simulation study, we find that E(S1) has a negative relationship with the decline
of ÃUC, while Var(S2), Var(S1), Cov(S1, X1 − X2) have positive relationships with
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the decline of ÃUC.
To apply this to practical use, we propose a SIMEX procedure to estimate these
two factors from real data, though the estimate is not very accurate. Then we define
a ratio of the decline of predictive accuracy due to measurement error compare to the
overall decline of predictive accuracy. If the ratio is large, the effect of measurement
error dominate the decline of predictive accuracy, otherwise, we do not need to worry
much about the measurement error. This could help researchers to decide whether to
improve technologies to measure the data more accurately or to use more advanced
regression techniques, find more relevant covariates or collect more samples to reduce
other errors causing the decline of predictive accuracy.
In chapter 3, we first define the overlap measure of the effect sizes of the marker/outcome
associations in two subpopulations, and then propose parametric and nonparametric
methods to estimate it. In simulation study, we compare the accuracy of the estimate
of the overlap measures through mle, moment, rescaling, copula and plug-in methods
and find out that if the joint distribution of the true standardized parameter (θAi ,
θBi ) is much deviated from bivariate normal distribution, the copula method per-
forms better than the other parametric or nonparametric methods. Then we apply
copula-based, mle and plug-in method to estimate the overlap measure of the com-
mon associations in each pairs of disease subgroups in CKD data. MLE estimator
and copula estimator give similar result for most of the pairs of disease subgroups,
implying that the joint distribution of the effect sizes in any two disease subgroups is
close to bivariate normal distribution.
In chapter 4, we address four issues. First, we assess the uncertainty of the prop-
erty/marker/outcome associations that are aggregated over large data sets within
complex and poorly understand dependencies. We show that commonly used ran-
domization approaches, while intuitive, can give misleading results, and we provide
a simulation based alternative approach that appears to perform well in a variety of
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situations. Second, we address the issue of marker/outcome relationships that are
strongly non-monotonic. We propose a function decomposition method and find out
that the monotone marker/outcome associations are more likely to exist in CKD data
than the “u-shaped” associations. Third, We use the quantile regression with spline
basis technique to model the relationships between the marker/outcome associations
and the five marginal properties with a L1 goodness of fit R1 in real data analy-
sis. We figure out that the skewness property has the strongest association with the
marker/outcome association and dominate the other marginal properties. At last,
the scientific meaning of the property/marker/outcome association is considered. We
conclude that for the highly skewed genes, people have gene expression level on the
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